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ABSTRACT
Endothelial cells (EC) are ubiquitous - as vascular epithelial cells they line the inner surface of all
vessels and are the contact surface with flowing blood. Macrovascular EC are the first line barrier
between flowing blood and mural structures. The microvasculature includes EC-lined vessels that contact
virtually every cell in the body. These EC are potent bioregulatory cells, modulating thrombosis,
inflammation and control over mural smooth muscle cells and vascular health.
The biochemical roles of EC can be retained when cells are embedded within three-dimensional
matrices without recapitulation of the full vessel architecture. Within these matrices, surface and
structural properties impose a set of forces on the embedded EC. Indeed, substrata pore size and modulus
have profound effects on phenotype and function of a range of cell types. In the first part of this work, we
examined the effect of pore size, matrix relative density and modulus on matrix-embedded EC growth and
secretion and found a greater biological dependence on modulus than pore size or density. In the second
part of this work, we examined the effect of isolated changes in modulus on BC growth, secretion of
growth regulators, and modulation of smooth muscle cell growth.
EC growth is maximal at intermediate moduli over a range from 50 Pa- 1500 Pa. Secretion of heparan
sulfate proteoglycans (HSPGs), which inhibit smooth muscle cell growth, is maximal at low moduli and
flat at high moduli. Secretion of growth factors such as FGF2 and PDGF-BB were also modulus
responsive. Inhibition of smooth muscle cell growth rose as modulus decreased from 510 Pa to 50 Pa and
was the result of a balance between increased HSPG secretion and reduced secretion of vasoactive growth
factors. Changes in endothelial function correlated with extracellular matrix gene and integrin aP 3 and
c41 expression. Changes in the forces experienced by the cell - a change in substrate modulus - cause the
cell to alter its ECM and integrin expression in an effort to return the force balance to normal, leading to
downstream effects on cell function. While growth stimulatory function largely conserved, growth
inhibitory function was altered to a much larger degree.
In the final part of this work, we examined the effect of scaffold modulus on EC response to
inflammatory stimuli, and attempted to correlate it to changes in smooth muscle cell regulation and
integrin expression. While cytokine secretion was independent of modulus, surface expression of ICAM- 1
and VCAM-1, and induction of CD4' T cell proliferation followed a similar pattern to smooth muscle cell
inhibition, suggesting that similar mechanisms may be involved in their regulation by substrate modulus.
Alteration of scaffold modulus has a profound impact on EC function including growth regulation
and inflammatory response. The model offered in this thesis - wherein EC attempt to neutralize changes
in environmental force balance by altering ECM and integrin expression, leading to changes in
downstream function - offers insight into how environmental changes effect functional changes in ECs.
Thesis supervisor: Elazer R. Edelman, M.D., Ph.D.
Title: Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology
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CHAPTER 1: INTRODUCTION AND BACKGROUND
INTRODUCTION
Endothelial cells, the cells which line all blood vessels in the body, have a wide range of
important functions, not only acting as a barrier between the blood and tissues, but also playing
roles in coagulation, fibrinolysis, regulation of vessel tone, regulation of smooth muscle cell
growth, response to inflammation and the formation of new blood vessels.' 2 In the last several
years, tissue engineering techniques have been used to develop endothelial cell constructs, using
commercially available surgical sponges, which can regulate these same functions in the absence
of an intact endothelium. By utilizing these constructs it has been possible to prevent neointimal
hyperplasia in animal models of angioplasty and arterio-venous fistula.
One of the initial motivations for this work was to determine if altering scaffold physical
properties could enhance embedded cell functionality. It has long been known that cells'
properties are affected by the physical properties of the substrate on which they are grown,
including, topography, roughness and rigidity. Changes in these properties can lead to alterations
in a wide range of cellular functions, ranging from proliferation and migration to cell specific
functions such as cytokine secretion.
Significant work has been performed to date to examine cell-substrata interaction and yet
the majority of these studies focus on cells grown in 2D cultures. To understand how cells
function in 3D, it is not always possible to extrapolate from 2D. Many cell types, including
fibroblasts3-5, smooth muscle cells 6, and endothelial cells7 act significantly differently in three
dimensional culture. Additionally, few of the studies which examine how changes in three
dimensional physical properties affect cells focus on endothelial cells.
Page 9 of 139
This thesis sought to examine the effects of several parameters, including pore size,
matrix density and matrix modulus, on endothelial cells cultured in three dimensional structures.
We found that endothelial cells do respond to these factors by altered growth and secretion, but
that modulus seemed to have a dominant effect over pore size or relative density. Based on the
results of the first part of this work, the remainder of the thesis examined the effect of isolated
changes in modulus on endothelial cell function, still in three dimensional culture.
The bulk of this work examines the hypothesis that endothelial cellfunction is altered by
substrate mechanical properties in a manner which is mediated by changes in the cell-
substrate interface, namely the extracellular matrix and integrins. This was accomplished by
carrying out the following specific aims:
1. To develop a system of tissue culture scaffolds which vary in modulus while retaining the
same physical structure.
2. To examine the effect of changes in scaffold modulus on aspects of endothelial cell
biology including regulation of growth, secretion, smooth muscle cell inhibition and
response to inflammatory stimuli.
3. To correlate changes in cell biology to changes in the cell-substrate interface.
4. And, finally, to develop a model which takes into account the data from aims 1-3 to
explain how changes in substrate modulus lead to modulation of endothelial cell function.
BACKGROUND
Substrate Mechanics and Cell Function
Substrate mechanics have long been known to affect both cellular morphology and
function. Many cell types have been shown to spread more on stiffer substrates- 11 or migrate
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towards regions of stiffer substratum9, 12-14 . Properties of fibroblasts, smooth muscle cells and
chondrocytes, including focal adhesion formation 8'1, tyrosine signaling15 1
6
, and proliferation17-19
are all affected by substrate mechanics across both 2D and 3D culture. Cell type specific
functions are affected by substrate rigidity. Hepatocytes grown on polyacrylamide gels with
different mechanical properties show differences in albumin production and p450 gene
20
expression. Mammary epithelial cells grown in stiff 3D collagen gels did not form acini, and
had increased FAK (focal adhesion kinase) phosphorylation along with more focal adhesions
containing vinculin, both associated with a malignant phenotype. Spinal neurons exhibit more
branching on softer substrates.
Less is known about the effect of substrate rigidity on endothelial cells than on other cell
types. To date, most studies using endothelial cells have looked at the effect of rigidity on the
physical state of the cells, rather than their functionality. For example, Gray et. al showed that
endothelial cells will migrate towards, and accumulate on, regions of increased stiffness when
cultured in 2D.12 Several studies have found that like other cell types, when cultured in 2D,
endothelial cells will show increased spreading and actin stress fiber formation on stiffer
substrates than on soft ones.23 8 24
Much of the work examining the effect of stiffness on endothelial cells has taken place in
2D. There have, however, also been a significant number of studies examining the effect of
stiffness on the morphology of endothelial cells in 3D culture. Tubulogenesis (or the formation
of tube-like structures) by endothelial cells is significantly affected by stiffness of the substrate in
which they are cultured. Studies have consistently found that endothelial cell tubulogenesis is
increased in softer gels compared to stiffer ones. Additionally, the morphology of the tubes
formed also varied with the substrate's mechanical properties. 25-28
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Beyond morphology, many studies examining alterations in endothelial cell function due
to changes in substrate rigidity have focused on integrins and focal adhesions. Wallace et. al
showed that focal adhesion structure in 2D culture was affected by stiffness, with smaller
23
adhesions found on softer materials. Yamamura et. al found a similar effect in 3D culture, with
increased expression of vinculin, a focal adhesion associated protein, in stiff gels compared to
softer ones.28 However, beyond adhesion, there is very little in the literature on the effect of
substrate stiffness on the function of endothelial cells.
The question of how substrate rigidity affects endothelial cell function is an important
one. In vivo, many diseases, such as atherosclerosis and hypertension 29,30, are associated with
altered vessel mechanical properties. In addition to clinical effects such as increased systolic
blood pressure and an association with increased cardiac death, these changes in mechanical
properties have also been linked to alterations in endothelial cell gene expression associated with
altered extracellular matrix deposition, integrin expression and cell signaling.
Tissue Engineered Endothelial Cell Constructs: Motivation
Knowing how endothelial cell function is affected by substrate stiffness, especially in
three dimensions, is important for tissue engineering applications as well. Endothelial cells
embedded in Gelfoam, a porous, 3D, gelatin surgical sponge, have been examined for over 10
years as a way to replace the functionality of a damaged endothelium without recapitulating its
structure. In this system, endothelial cells are engrafted within the Gelfoam and allowed to grow
to confluence. At confluence, the cells produce the same mix of growth factors and heparan
sulfate proteoglycans as endothelial cells cultured in two dimensions. Conditioned media from
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these cells is able to inhibit smooth muscle cell growth in much the same way as conditioned
media from cells cultured on TCPS.
When implanted perivascaularly, these constructs show great promise in the prevention
32-34
of restenosis after balloon angioplasty. Early studies examined the ability of bovine
endothelial cells on Gelfoam to inhibit hyperplasia in rat carotid arteries denuded with balloon
angioplasty. Intimal hyperplasia 14 days after endothelial denudation was reduced by 88.2%
versus controls, and versus only 61.8% by the local delivery of heparin.35 The mechanism behind
this reduction was related to heparan sulfate proteoglycan secretion by the endothelial cells.36
Similar results were seen in a porcine model of carotid artery angioplasty. Intimal hyperplasia
was reduced at both 4 weeks (54% with allogenic cells, and 46% with xenogenic [bovine]
endothelial cells)33 and 3 months (56% and 31% for porcine and bovine endothelial cells,
respectively). It should be noted that this later time point was taken approximately 2 months
after the implant itself had degraded, indicating that the implant's function lasts long beyond its
physical presence.
Endothelial cell implants have promise in the setting of arterio-venous fistula creation for
dialysis access. Only 60% of these are fistulae are patent at one year, due to intimal hyperplasia
of the venous side of the fistula caused by increased vascular pressures. Allogenic endothelial
cell implants reduce intimal hyperplasia by 35% at one month and 68% at two months compared
to a sham implant.34 A-V grafts similarly benefit from endothelial cell implants, with a reduction
of stenosis of 81% at 28 days.37 Use of Gelfoam implants for A-V fistulae has moved to clinical
trials, and has recently completed Phase 2 testing.3 8
In addition to their clinical use, these constructs have the elicited the interesting
observation that they cause only a weak immune response after implantation, even when using
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xenogenic cells.7 Endothelial cells embedded in Gelfoam express significantly lower levels of
surface adhesion molecules such as ICAM, VCAM, selectins, and MHCs in response to
inflammatory stimuli. Cytokine secretion and CD4+ T cell proliferation are also markedly
reduced.7 Other effects seen in vitro include decreased induction of dendritic cell maturation,
decreased immune response of splenocytes on exposure to endothelial cells, and alterations in the
NF-kB pathway. 1-4' These results are translated in vivo as well. Allogenic and xenogenic
endothelial cell implants elicit a much dampened immune response to embedded endothelial
cells than to free endothelial cells, in both naive and pre-sensitized mice.7 42 43
The original choice of Gelfoam as the scaffold used for supporting endothelial cell
growth was based on availability. Although these constructs have been very effective, and
display an interesting ability to modulate the immune response, it may be possible to improve
their performance. Knowing how the scaffold's physical and mechanical properties affect
endothelial cell function may allow for further optimization of this system in addition to offering
insights into endothelial cell biology.
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CHAPTER 2: EFFECT OF SCAFFOLD PORE SIZE, DENSITY
AND MODULUS ON ENDOTHELIAL CELL GROWTH AND
SECRETION
MATERIALS AND METHODS
Production of Gelatin Scaffolds
Gelatin scaffolds with varying structures and mechanical properties were created using a
foaming method based on the procedure outlined in the original patent for Gelfoam, a porous
gelatin surgical sponge.44 Type A porcine skin gelatin was dissolved in distilled water to
concentration of 3-6% (wt/vol) and heated to 37 0C. 200mL of gelatin solution was transferred to
a beaker and placed in a 34 0 C water bath (to keep solution from hardening without causing foam
to melt). An overhead mixer (VWR) was fitted with either a whisk-like Squirrel mixing head
(Smooth-on) or a standard propeller. The gelatin solution was mixed at high speed for 5 minutes,
creating a thick, white foam which was spread into polypropylene molds. Foams dried at room
temperature for 2 days in a laminar flow hood. After trimming to approximately 0.5cm thick,
foams were crosslinked and sterilized by placing in sealed heatproof bags and heating in an oven
at 145 0C for 3 hours. The end-result was a porous, insoluble, sterile gelatin sponge which could
be used for cell culture. Two commercially available gelatin sponges, Gelfoam and Surgifoam,
were used in addition to the scaffolds made as described above. Scaffold nomenclature is as
follows: for lab made scaffolds, percentage of gelatin followed by the mixed type (i.e. a 5%
gelatin solution scaffold made with a Squirrel mixing head is referred to as 5S, while a 3%,
propeller mixed scaffold is 3P). Gelfoam is referred to as GF, and Surgifoam as SF.
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Characterization of Scaffold Density, Pore size and Mechanical Propertiess
Dry scaffolds were cut into lcmxlcm or lx2xO.5cm pieces and dimensions confirmed
using calipers. The mass of each sample was then weighed using a balance with an accuracy of
0.1mg. Density was calculated as mg mass per cm 3 . Scaffolds were visualized using a Hitachi
S3400 scanning electron microscope in low vacuum mode at a magnification of 40x, under
1 0OPa of pressure, in backscatter mode with a 15kV beam. After imaging, each visible pore was
outlined by hand using a tablet PC with ImageJ software. (Figure 1) The same software
calculated the diameter and circularity of each pore. Scaffold stiffness was characterized by
uniaxial compression. An Instron 8848 Microtester with a 20N load cell compressed the
scaffolds at a rate of 0.02mm/s. Young's modulus was calculated from the initial slope of the
resulting stress-strain curve.
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Figure 1: Scaffold SEM Images for Pore Size Measurement. Scaffolds were imaged with
SEM (Above). The contrast was adjusted make pores easier to see and then individual pores
were outlined and diameter measured using ImageJ software. (Below) The scaffold shown here
is 6S (6% gelatin made with a Squirrel mixer).
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Cell Isolation and Culture
Endothelial cells (PAEC) were isolated from porcine aortas using collagenase and
cultured in phenol red free Dulbecco's modified Eagle's medium (DMEM) supplemented with
10% fetal bovine serum (FBS), 1% penicillin-streptomycin, and 2% glutamine. Media was
changed three times per week, and cells were used between passages four and eight. For
engraftment onto scaffolds, PAEC were trypsinized, resuspended at ix106 cells/mL in culture
media and 1 00ml of cell suspension pipetted evenly onto 1 x2cm scaffolds. Scaffolds were
incubated for 2 hours at 37C, transferred to 3OmL polypropylene tubes with IOmL of culture
media and maintained at 37C, 10% CO 2 with regular media changes. For experiments requiring
free cells, cells were recovered by digestion in collagenase IV in PBS at 37C. After gelatin
scaffolds were completely digested, cells were recovered by centrifuging.
Cell Visualization Using Environmental SEM
PAEC seeded on Gelfoam were visualized with environmental scanning electron
microscopy using an FEI/Philips XL30 FEG ESEM with a cooled stage. Samples were fixed
with 4% paraformaldehyde overnight at 40C and washed thoroughly with distilled water. Wet
samples were placed directly on the microscope stage and imaged using a 15kV beam in
secondary electron mode. The microscope stage was kept at I 0C, and the relative humidity in the
sample chamber was kept above 50% (water vapor pressure above 2 torr) to ensure that the
sample did not dry out during imaging.
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Cell Visualization Using Quantomix WetSEM Capsules
PAEC seeded on Gelfoam were imaged inside Quantomix WetSEM tissue capsules,
which allow visualization of tissues under high vacuum in the hydrated state. Samples were fixed
with 4% paraformaldehyde overnight at 40C and washed thoroughly with PBS. A 2mm biopsy
punch was used to cut small samples from the Gelfoam block, and these were further washed
with distilled water and stained with 0.5% uranyl acetate for 20 minutes a room temperature.
Stained samples were washed three times with distilled water. Some samples were immuno-
stained for CD31 (PCAM, an endothelial cell specific cell adhesion molecule) prior to uranyl
acetate staining. Samples were blocked 15 minutes in 1% bovine serum albumin (BSA) in PBS
followed by incubation with primary antibody (1:10 dilution of mouse anti-CD31 in
1%BSA/PBS) overnight at 40C with shaking. Samples were washed extensively with 1%
BSA/PBS then incubated with goat anti-mouse IgG antibody conjugated with 0.8nm gold beads
(1:50, Aurion) overnight at 40C. Samples were then washed extensively with PBS, post-fixed for
eight minutes with 2% gluteraldehyde at room temperature, and washed extensively with
distilled water. Gold staining was silver enhanced using an Aurion SE-EM silver enhancement
kit and then stained with uranyl acetate as described above. Stained samples were placed in a
Quantomix tissue caspsule and imaged using a Hitachi S3400 SEM in backscatter mode with a
10-18kV beam voltage.
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Cell Growth
Scaffold were cut to lxlcm, seeded with 4.5xI 04 PAEC and cultured for up to 19 days
under normal culture conditions. On days 0, 2, 5, 9, 14 and 19, cells were recovered from 3
scaffolds of each type and counted using a Coulter Counter.
Preparation of Conditioned Media
Endothelial cell conditioned media was prepared by incubating confluent Ix2cm
scaffolds (n=3 for each scaffold type) in 1 OmL serum free DMEM + PSG for 24 hours.
Conditioned medium was then collected, centrifuged to remove any particulates, and the
supernatant frozen at -80C until use. Cells were recovered from scaffolds and counted using a
Coulter Counter.
Total Protein, TGF-fl, Prostacyclin Assays
Total protein in conditioned medium was measured using a bicinchoninic acid (BCA)
protein assay (Pierce) according to kit directions. TGF-31 in conditioned medium was quantified
using a TGF-31 ELISA (R&D) according to kit directions. Prostacyclin has a very short half life,
therefore its breakdown product 6-keto-prostaglandin Fl, was measured in conditioned medium
using an EIA kit (Amersham) according to assay directions. All measured values were
normalized to cell number.
Glycosaminoglycan Quantification
Conditioned media was concentrated 2x using 3000 MWCO centrifugal concentrators
(Millipore). Total glycosaminoglycan and heparin sulfate proteoglycan in the concentrated media
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was measured using a dimethylmethylene blue (DMB) assay. DMB assay solution was prepared
according to the method of Farndale et. al.45 To
determine the total amount of GAG in samples, 700pl DMB was added to a 500pl sample and
absorbance was immediately read at 523 nm using a spectrophotometer (Perkin-Elmer) and
compared to a standard curve prepared using chondroitin sulfate in serum free DMEM. To
determine the amount of heparan sulfate (HSPG) in the samples, conditioned media was digested
with 0.036U/mL protease-free chondroitinase ABC for 3 h at 37 0 C prior to measurement of
GAG with DMB. The GAG remaining after digestion was considered to be the HSPG fraction.
All samples were measured with and without chondroitinase digestion, in duplicate.
Statistics
Data are presented as mean +/- standard error (SEM) unless noted. Groups were
compared using one way ANOVA. A value of p < 0.05 was considered significant.
RESULTS
Mechanical Characterization of Gelatin Scaffolds
The Young's modulus of bulk gelatin scaffolds was measured by compression using an
Instron mechanical tester. (Figure 2) Scaffold modulus increased with the concentration of
gelatin used in the foaming solutions. Additionally, modulus increased at each gelatin
concentration when matrices were formed with a propeller rather than the Squirrel mixing
attachment. Moduli of the prepared scaffolds ranged from 20.4kPa for scaffold 3S up to
278.5kPa for scaffold 5P. Gelfoam and Surgifoam, the commercial gelatin foams, bracketed the
gelatin scaffolds produced in the lab, with a modulus respectively at the low (47.6kPa) and high
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(291.4kPa) ends of the measured range. Statistics were not performed, as only one sample of
each type was measured. (Nomenclature, as outlined in Methods, holds here: # = % gelatin
solution, S = Squirrel Mixer, P = Propeller Mixer, GF = Gelfoam, SF = Surgifoam)
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Figure 2: Bulk Young's (Compressive) Modulus of Gelatin Scaffolds. Strain rate =
0.02mm/s. Alteration of gelatin concentration and mixer type led to different scaffold mechanical
properties. Nomenclature: # = % gelatin solution, S = Squirrel Mixer, P = Propeller Mixer, GF =
Gelfoam, SF = Surgifoam.
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Physical Characterization of Gelatin Scaffolds
Scaffold density (mass per volume), calculated from dimensions and mass, increased
with gelatin content. Scaffolds made with the propeller mixer were denser. (Figure 3)
Accordingly, the least dense sample was 3S (7.73 +/- 0.18 mg/cm 3), and the most dense 5P
(17.99 +/- 2.40 mg/cm 3). As with modulus, Gelfoam and Surgifoam fell towards the low and
high ends of the density range, respectively. Unlike with true, porous, isotropic structures,
density was linearly related to scaffold modulus. (Figure 4) Only Surgifoam did not fit this
relationship, possibly due to a difference in the base material. (Surgifoam is made of gelatin, but
the exact type and method of production/cross-linking is not known.)
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Figure 3: Scaffold Density. Alteration of gelatin concentration and mixer type led to changes in
scaffold density. In general, increased gelatin concentration and use of a propeller mixer led to
increased density. Nomenclature: # = % gelatin solution, S = Squirrel Mixer, P = Propeller
Mixer, GF = Gelfoam (uncompressed), SF = Surgifoam (uncompressed). Data expressed as
mean +/- SEM, n=3.
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Figure 4: Modulus vs. Scaffold Density. Scaffold density was mostly linearly related to
modulus. However, Surgifoam did not fit this linear relationship.
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Pore size was measured by imaging scaffolds (Figures 5-6) and using ImageJ software to outline
individual pores and measure their diameter. Scaffold pore size decreased with increased gelatin
content, and scaffolds made with the propeller mixer had smaller pore sizes. (Figure 7-8) Pore
size was not normally distributed, with many more small pores present than large ones in all
scaffolds. Maximal average pore diameter was measured in scaffold 3S (263tm) and minimum
average pore diameter in scaffold 6S (1 33pm). Gelfoam and Surgifoam had average pore
diameters of 212ptm and 157ptm respectively. Although these were the average pore sizes
measured, pores as large as 600ptm were seen in all scaffold types. Qualitative differences could
be seen in scaffold structure as well. The commercial scaffolds (Gelfoam and Surgifoam)
appeared to have thinner pore walls than the scaffolds produced in the lab, and a higher degree of
pore interconnectedness. The lab made scaffolds, especially those made using the propeller
mixer, clearly had pores which were walled off from their neighbors. These isolated pores were
excluded from analysis.
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Figure 5: Macroscopic Images of Selected Scaffolds. a)Gelfoam, b) Surgifoam, c)4S, d)3P,
e)5P. Scale bar is 1.25cm.
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Figure 6: SEM Images of Scaffolds. Scaffolds were imaged with SEM for pore size analysis.
A) Gelfoam, B) Surgifoam, C) 3S, D) 4S, E) 5S, F) 6S, G) 3P, H) 5P, Commerical scaffolds
(Gelfoam, Surgifoam) appear to have thinner pore wall than those made in the lab. Additionally,
the scaffolds made with a propeller mixer do not appear have fully interconnected pores (Some
pores are clearly walled off and were not used in analysis).
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Figure 7: Pore Diameter. Points represent the average diameter of at least 250 individual pores
across 3 fields. Bars represent the standard deviation of pore size within this sample group.
(Larger bars = more heterogeneity)
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Figure 8: Change in Pore Size Distribution With Gelatin Content Depends on the Type of
Mixing Head Used. Top: Change in pore size distribution when using Squirrel mixing
attachment. As gelatin content decreases (from 6% to 3%), the mean pore size not only increases
(the peak of pore size vs. number fraction moves to the right), but the distribution of pore sizes
becomes flatter, with more very large pores. Bottom: Change in pore size distribution when
using a propeller mixing attachment. As gelatin content decreases (from 5% to 3%), mean pore
size increases, mainly due to a shift in the entire curve to the right. The width of the number
fraction peak remains approximately the same.
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Visualization of Cells on Gelatin Scaffolds Using SEM
Two methods were used image endothelial cells within the gelatin scaffolds:
environmental SEM and conventional SEM paired with Quantomix WetSEM capsules. Gelfoam
containing endothelial cells were imaged by environmental SEM was in a cold (1 C) chamber
with a humid atmosphere in secondary electron mode. Cells were extremely difficult to see using
this method. (Figure 9) There was essentially no contrast between the cells and the scaffold, so
cells were only able to be identified by their nuclei and edges. Cell-cell boundaries were even
more difficult to discern. However, it was still possible to appreciate the way in which cells were
wrapped around individual struts of the scaffold, and to see that cells were not completely
confluent. That is, areas of scaffold were visible between individual cells. Overall, however, this
method was not ideal for in situ imaging. Several images of cells taken using this method are
shown below, with a cell free scaffold for comparison.
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Figure 9: Environmental SEM Images of Endothelial Cells on Gelfoam. Top: Cell free
Gelfoam. Note the smooth walls. Middle: EC on Gelfoam. Note more textured walls, nuclei
(white arrows), and cell projections and cell-scaffold boundaries (black arrow). Bottom: High
magnification (1500x) image of EC on Gelfoam. Note that the cell-cell boundary is not
continuous and that the scaffold is visible between the cells.
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The second method used to visualize cells directly in the scaffold used Quantomix
WetSEM tissue capsules to visualize uranyl acetate stained endothelial cells on Gelfoam. (Figure
10) Cells imaged using this method were much more clearly visible than those imaged with
environmental SEM. Cell-scaffold boundaries and nuclei were extremely clear, though cell-cell
boundaries were still not clearly visible. This technique also had the advantage that uranyl
acetate staining allowed fine details of the plasma membrane or cytosol to be visible as well (as
can be seen in the image below). However, all structural information about the scaffold itself was
lost with this technique. Scaffolds placed in the imaging capsules were compressed, masking any
information about the scaffold's pores, and the way the cells interacted with them.
To gain more information about cell interaction, immuno-staining for PCAM was
attempted. (Figure 11) Samples were immunostained, labeled with a gold conjugated secondary
antibody and silver enhanced before imaging within the WetSEM capsules. While the staining
was clearly visible, the process of labeling and silver enhancement appeared to destroy some of
the benefits created by imaging in the capsules. Although the cell-scaffold boundary was still
clear, the detail of the cell membrane was lost. Additionally, charging artifacts, which were
already a problem when using the capsules, became much worse and made it nearly impossible
to capture high quality, high magnification images. Finally, although it was possible to easily
stain for surface molecules like PCAM, staining for intracellular or subcellular molecules (such
as vinculin or integrins) was not successful. WetSEM proved useful for imaging of overall cell
morphology. However, it was not ideal for immuno-staining or imaging cell interaction with the
pore structure of the scaffold.
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Figure 10: WetSEM images of endothelial cells on Gelfoam. Top: Low magnification (85x)
image of uranyl acetate stained EC. Note that scaffold is compressed and pore structure is lost.
Middle: 500X. Bottom: 900x. Note that cell-scaffold boundary is clear, but cell-cell boundaries
are not. Fine details of the cell membrane are visible at this magnification.
Page 33 of 139
Figure 11: PCAM Stained Endothelial Cells Imaged with WetSEM. Top: 500x. Note that
cell-cell boundaries (white arrow) are now clear, but at a loss of fine cell detail. Bottom: PCAM
stained EC, 210OX. Again, cell-cell boundaries (white arrow) are clear, but fine detail is lost, and
charging artifacts (black arrow) are severe.
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Endothelial Cell Growth
PAEC were seeded onto scaffolds and allowed to grow for up to 19 days. Cells were
recovered from scaffolds and counted on days 0, 2, 5, 9, 14 and 19. Cell number increased
rapidly between days 0 and 5 for all scaffold types. (Figure 12) After day 5, cell number either
plateaued or increased much more slowly until day 19. Final cell number, at day 19, was
significantly affected (p < 0.008 by ANOVA) by scaffolds produced in the lab, ranging from a
low of 257.4 +/- 16.9 x 103 cells for scaffold 5S to a high of 389.6 +/- 24.8 x 103 cells for
scaffold 5P. (Figure 13) Final cell number was independent of gelatin concentration but did
correlate with modulus and density. A parabolic curve can be fit to these data with an r2 ~0.8.
Interestingly, both the commercial sponges included in the study (Gelfoam and
Surgifoam), supported significantly higher cell numbers than any of the lab made scaffolds, and
do not fall on the cell number/density best fit curve, although they fall on opposite ends of the
measured ranges of all measured physical parameters. The reason for this is not clear, but it is
possible that the commercial scaffolds have a different chemistry or are cross-linked differently
than the scaffolds made in the lab.
Page 35 of 139
800-
+-.GF +SF +3S +4S +5S +6S +3P -e-4P +5P
600 -
0
0 4 8 12 16 20
Time (Days)
Figure 12: Cell Number vs. Time. Cell number increases at a rapid rate until day 5, and then
more slowly until day 19.
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Figure 13: Final Cell Number (Day 19) vs. Scaffold Modulus. Cell number on lab-made
scaffolds is fit by a parabolic curve with an r2 = 0.78. Although the correlation is fairly good, the
changes in absolute cell number are very small. Gelfoam and Surgifoam (the commercial
scaffolds) are outliers to this curve.
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Secretion of Regulatory Factors is Related to Scaffold Properties.
Total secreted protein in conditioned media was measured using a BCA assay and
normalized to cell number. (Figure 14) Measured values ranged from 5.34 +/- 0.35 mg/10 6 cells
for Gelfoam to 9.12 +/- 0.88 mg/10 6 cells for scaffold 6S. Although ANOVA analysis showed
that scaffold type has a significant effect on total secreted protein (p < 0.0006), there was no real
correlation between protein and any of the measured scaffold parameters. (Figure 15). Total
protein secreted per scaffold (irrespective of cell number) was also dependent on scaffold type (p
< 0.04 by ANOVA), and linearly related to scaffold density (r2 0.7). (Figure 16) This suggests
that the scaffold itself may be interfering in the measurement of total protein, perhaps through
degradation or retention of serum containing medium.
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Figure 14: Total Secreted Protein (Normalized to Cell Number) Top:
size. Middle: Versus scaffold density. Bottom: Versus scaffold modulus.
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Figure 15: Total Protein per Scaffold Versus Scaffold Density. Total protein per scaffold was
linearly related to scaffold density, suggesting that the scaffold itself may be interfering in the
protein measurement.
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Conditioned media was assayed for total TGF-pI, a molecule which regulates cell
proliferation and extracellular matrix deposition, by ELISA and normalized to cell number.
(Figure 16) TGF-P3 levels were significantly dependent on scaffold type (p < 0.0009 by
ANOVA), and range from 1.10 +/- 0.28 ng/10 6 cells for scaffold 3S up to 4.08 +/- 1.14 ng/10 6
cells for scaffold 3P. This difference in TGF-P3 levels is large enough to be functionally
significant. TGF-P levels did not correspond to scaffold pore size. However, TGF-p3 was
related to scaffold modulus by a parabolic fit with a maximum at mid-range moduli, yielding an
r2 - 0.6. Although there is a linear relationship between the modulus and density of most
scaffolds, Surgifoam does not follow the E ac p relationship, and does not allow for good
correlation between density and TGF-pI (r 20.3).
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Figure 16: Total TGF-01 (Normalized to Cell Number) Top: Versus pore size. Middle:
Versus density. Bottom: Versus modulus. There is no clear relationship between TGF-p1 and
pore size or density. However, TGF-p3 is related to scaffold modulus by a parabolic curve which
has a maximum at mid range moduli, with an r2 = 0.61.
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The level of prostacyclin, a vasodilator, in conditioned media could not be measured
directly due to its short half life. Instead, 6-keto-prostaglandin Fia, a breakdown product of
prostacyclin, was measured using an EIA kit. (Figure 17) The level of prostaglandin varied
significantly with scaffold type (p = 0.001 by ANOVA), ranging from 8.21 +/- 0.61 ng/10 6 cells
for Surgifoam to 17.48 +/- 0.41 ng/10 6 cells for scaffold 6S. However, prostaglandin level did
not strongly correlate with any of the measured scaffold parameters. The closest match, modulus,
correlated only slightly with prostaglandin levels (r2 = 0.49 for an inverse parabolic fit).
(Similarly to TGF-bl, although there is a linear relationship between the modulus and density of
most scaffolds, Surgifoam does not follow the E oc p relationship, and does not allow for good
correlation between density and prostacyclin [r 2<0.1].) The reason for this is not clear. It is
possible that more than one parameter plays an important role in prostacyclin levels,
confounding the data, or that some non-measured parameter is playing a role.
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Figure 17: Prostacyclin (Normalized to Cell Number). Top: Versus pore diameter. Middle:
Versus scaffold density. Bottom: Versus scaffold modulus. Although levels of prostacylin vary
significantly between scaffolds (p = 0.001 by ANOVA), its levels do not correlate well with any
the measured parameters. The best fit is a parabolic curve with r2=0.49 fit to the data of the
modulus vs. prostacyclin graph.
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Total sulfated glycosaminoglycan and heparan sulfate proteoglycan were measured in
conditioned media using a DMB assay. These are molecules secreted by confluent endothelial
cells, which play an important role in the endothelial cell mediated regulation of smooth muscle
cell inhibition. Total GAG ranged from a low of 4.99 +/- 0.36 ptg/10 6 cells for scaffold 3S to a
high of 13.73 +/- 1.81 ptg/10 6 cells for scaffold 6S. (Figure 18) HSPG ranged from 3.47 +/- 0.16
Ig/10 6 cells for scaffold 3S to 9.74 +/- 0.96 Vtg/10 6 cells for scaffold 3P. (Figure 19) Although
these differences are large secretion of both total GAG and HSPG did not significantly affected
by scaffold type given the large errors on the data (p > 0.2 for both by ANOVA). (However,
when the scaffold type with the largest error bars is removed from the analysis (scaffold 6S), the
change in HSPG with scaffold type does become significant. This suggests that the changes seen
may be real, but are being masked by the large error bars generated using this method.)
Total GAG did not correlate with either pore size or scaffold density. However, scaffold
modulus and total GAG were able to be related using an inverse parabolic curve (r2 - 0.74).
Similarly, HSPG did not correlate well with either pore size or density, but did somewhat
correlate with modulus. Like with total GAG, an inverse parabolic curve provided an acceptable
fit (r 2 ~ 0.72) between HSPG and scaffold modulus. (Similarly to TGF-bl and prostacyclin,
although there is a linear relationship between the modulus and density of most scaffolds,
Surgifoam does not follow the E oc p relationship, and does not allow for good correlation
between density and either total GAG [r 2 -0.5] or HSPG [r 2 -0.5].)
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Figure 18: Total GAG Secretion by Endothelial Cells Top: Versus pore size. Middle: Versus
scaffold density. Bottom: Versus scaffold modulus. It was seen that GAG secretion was not
correlated to either pore size or density, although there was a fairly good correlation between
sulfated GAG and scaffold modulus (r 2 = 0.744 for a parabolic fit).
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Figure 19: HSPG Secretion by Endothelial Cells Top: Versus pore size. Middle: Versus
scaffold density. Bottom: Versus scaffold modulus. It was seen that HSPG secretion was not
correlated to either pore size or density, although there was a fairly good correlation between
HSPG and scaffold modulus (r2 = 0.717 for a parabolic fit).
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None N/A
IGF-$1 Modulates cell proliferation Modulus 164kPa
and ECM deposition
HSPG Inhibits smooth muscle cell Modulus 164kPa
growth
Prostacyclin Vasodilator, inhibits platelet None /A
aggregation
Table 1: Summary of Chapter 2 Secretion Data. Peak refers to the peak of the curve fit to the
relevant data.
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DISCUSSION
Previous studies utilizing a variety of cell types have shown that three-dimensional
structure and mechanical properties can have a significant effect on cells grown in scaffolds.
Many different cell types are sensitive to aspects of structure such as pore size or porosity. Pore
size has been shown to affect the attachment and proliferation of a variety of cell types, including
fibroblasts46, vascular smooth muscle cells 47'48 and MC3T3 osteogenic cells49 . It has additionally
been shown to affect cell type specific functions, including cartilage production by
chondrocytes', the differentiation of mesenchymal and embryonic5 stem cells, and bone
formation by bone marrow stromal cells5 3 . Similarly many types of cells are sensitive to scaffold
mechanical properties. Mammary epithelial cells2 1, chondrocytes 54 and endothelial cells 25-2 8 all
have cell type specific functions (formation of acini, cartilage production, and tubulogenesis
respectively) which are altered by substrate stiffness in three dimensions.
The aim of the first section of this thesis was to elucidate the effect of scaffold physical
properties, including pore size, density and modulus on endothelial cell functions other than
tubulogenesis. To achieve this aim, gelatin scaffolds with different physical properties were
prepared using a foaming method based on the procedure outlined in the original patent for
Gelfoam, and utilizing different percentages of collagen and different mixing heads. Using this
technique, and with the addition of two commercial gelatin sponges, it was possible to obtain
scaffolds with average pore diameter ranging from 133tm up to 263ptm, a 2.3x change in
density, and a 14x change in modulus.
In general, all scaffolds appeared to be able to support "normal" endothelial cells. Cells
on all scaffolds were able to proliferate, form cobblestone structures (though they did not cover
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the entire available area) and secrete regulatory factors such as TGF-P1, prostacyclin,
glycosaminoglycans and heparan sulfate proteoglycans. However, the alterations in scaffold
structure did appear to make a difference in the level at which many of these functions occurred.
For example, although all cells supported growth, cell number at confluence depended
significantly on scaffold type. When taken as a complete group, there was no correlation between
cell number and any of the measured scaffold properties. However, when only the lab made
scaffolds were taken into account, there was some correlation of cell number with modulus,
though not with pore size or density. (The lack of correlation with scaffold density despite the
largely linear relationship of density with modulus is due to Surgifoam not following the E oc p
curve and reducing the r2 values of correlation fits to below 0.5.) Overall cell function seemed to
correlate more strongly with scaffold modulus than with scaffold structure. In the range
examined, TGF-pl, GAGs, HPSGs and, to some extent, prostacyclin, were all were nonlinearly
related to modulus, while no correlation was seen with pore size or density. (Summarized in
Table 1.)
Interestingly, TGF-P3 and HSPG secretion were linearly related to each other, as well as
correlating with scaffold modulus. The relationship of these molecules to scaffold modulus, and
each other, is not completely unexpected. It has been previously reported in the literature that
mechanical stimuli upregulate both TGF-p and HSPGs in endothelial cells through a common
pathway. In our system, cells are not mechanically stressed, but the scaffolds do provide
different mechanical environments, which may act in a similar way.
The data gathered in this part of the thesis strongly suggested that modulus plays a larger
role in affecting endothelial cell function than pore size or scaffold density, at least in the ranges
of those properties examined here. It is still possible that pore size is important for endothelial
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cell function. The range of moduli examined in this work was significantly larger than the range
of pore sizes. It is entirely possible that the range of pore sizes at which endothelial cell function
is altered may not have been hit upon by this scaffold preparation method. Zeltinger et. al.
showed that a transition in endothelial cell growth structure (from disconnected webs to
confluent multi-layers) takes place at a pore size of-38pim, while a range of larger pore sizes has
no effect.48 If this pore size, which is much smaller than the average pore size of any of the
scaffolds used in this study, is indicative of the range at which endothelial cell function is
affected, the effect of pore size would not necessarily been seen here. Additionally, the very
large pore size distribution within each scaffold could have masked any effects of pore diameter
as well, as large pores would be offset by small pores, and vice versa.
Based on these data, it was decided that future research efforts would focus on examining
the effect of only modulus on endothelial cell function, rather than the effect of scaffold physical
properties as a whole. The current system of scaffold production makes it impossible to change
only one scaffold property at a time. In our system, scaffold modulus and pore size are related,
albeit in a complex rather than linear manner.
In addition to adding the confounding factor of pore size to changes in modulus, the
interaction between mechanical properties and structure means that it is difficult to know what
the modulus of the material under the cell is (the modulus of the scaffold strut itself). Scaffold
bulk modulus is linearly related to strut modulus, but only ifthe ratio of scaffold density to the
density of the scaffold material (in this case gelatin) is unchanged. In our system, bulk modulus
changes, but, assuming that the density of gelatin is constant as all solutions were prepared and
cured in a similar manner, so does the ratio of bulk density to material density. This means that
the modulus the cell sees may not be changing in the same way as the bulk scaffolds'. For
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example, it is possible that, because they are made from the same percentage gelatin solution,
scaffolds 5S and 5P have the same strut modulus, and that their bulk modulus only differs due to
changes in structure. In fact, there is some evidence that this is occurring. When data for TGF-
P1, GAG, HSPG, and prostacyclin secretion are compared with gelatin concentration, the points
for 4% gelatin and 5% gelatin fall almost exactly on top of one another, irrespective of mixer
type. For prostacyclin, the same holds true for the 3% gelatin scaffolds as well.
This means that to study modulus in isolation, a new system of scaffolds would need to
be devised in which the modulus of the scaffold material was altered while leaving structure
unchanged.
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CONCLUSIONS
Scaffold physical properties can significantly impact the secretory function of endothelial
cells cultured in three dimensions. Scaffold modulus plays a larger role in this impact than either
pore size or scaffold density. Thus, the remainder of the work in thesis will focus on examining
the effect of an isolated change in scaffold mechanical properties on endothelial cell function.
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CHAPTER 3: EFFECT OF SCAFFOLD MODULUS ON
ENDOTHELIAL CELL REGULATION OF GROWTH AND
SMOOTH MUSCLE CELL INHIBITION
INTRODUCTION
In Chapter 2 we found that the effect of scaffold modulus was dominant over that of pore
size or relative density on the function of endothelial cells. Based on those results, it was decided
to focus on the effect of isolated changes in scaffold modulus.
The first aim of this chapter was to develop a system of scaffolds in which only one
physical parameter, modulus, was altered. Scaffold bulk modulus is related to the relative density
of the scaffold, the modulus of the material from which the scaffold is made, and the density of
the material from which the scaffold was made. By choosing one scaffold structure and then
adding chemical crosslinks, it was possible to alter the modulus of the base material, and
therefore of the scaffold, even while keeping the other two parameters the same. Gelfoam was
chosen as the base scaffold material because the biology of endothelial cells grown within it has
7,32-343
already been well characterized.,-
The second aim of this chapter was to determine how changes in substrate modulus affect
endothelial cell growth and secretion of several growth regulatory factors found in healthy
endothelial cells including TGF-pl, FGF2, PDGF-BB and heparan sulfate proteoglycans. The
third aim was to correlate any changes in secretion of growth regulators to changes in endothelial
cell functionality, namely smooth muscle cell growth inhibition.
The next aim was to determine if changes in secretion and functionality were related to
changes in the interface between the cells and their substrate - the extracellular matrix and
integrins. Finally, we attempted to create a model which could explain how the endothelial cell
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growth regulatory system is mediated by substrate modulus and changes in the cell/substrate
interface..
METHODS
Alteration of Gelfoam Modulus
Gelatin scaffolds of varying modulus were created by modifying a commercially
available gelatin surgical sponge (Gelfoam). Three different methods were examined to alter the
mechanical properties of the sponge. First, scaffolds were heat treated at 145 0 C for 0, 6 or 24
hours to increase gelatin crosslink density and increase scaffold modulus. Second, scaffold
modulus was altered through carbodiimide chemistry. 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDAC, EMD Biosciences) and N-
hydroxysuccinimide (NHS, Thermo Scientific) created amide bonds between the amine and
carboxyl groups of gelatin.5 4'56 Scaffolds were hydrated and incubated in a sterile solution of
EDAC/NHS in PBS twice for 1.5 hours at room temperature with shaking, followed by 4, 15
minute washes with sterile PBS. The concentrations of EDAC and NHS were varied (54.0/22.0,
36.1/14.6, 9.0/3.6, 3.6/1.4 EDAC/NHS mM) to create different degrees of cross-linking, and
therefore different degrees of stiffness. Finally, scaffolds of reduced stiffness were created by
autoclaving Gelfoam in PBS for either 10 or 20 minutes at 121C. Only scaffolds created by
EDAC/NHS crosslinking and autoclaving, in addition to unmodified Gelfoam, were used for
further experiments. All scaffolds were stored in sterile PBS at 4C until use.
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Scaffold Mechanical Property Characterization
Scaffold stiffness was characterized by uniaxial compression using a Zwick mechanical
tester with a 20N load cell. 12mm disks of hydrated scaffolds were cut using a biopsy punch.
Scaffolds were immersed in a PBS bath and compressed at a rate of 0.01mm/s, and the Young's
modulus calculated from the initial slope of the resulting stress-strain curve.
Endothelial Cell Culture and Scaffold Engraftment
Human aortic endothelial cells (HAEC) from three healthy donors were purchased from
Promocell, pooled and used between passages 5 and 8. Prior to scaffold engraftment, cells were
cultured on dishes coated with 0.1% type A porcine gelatin for 30 minutes. Cells were
maintained in endothelial cell growth medium 2 (ECGM2, Promocell) supplemented with 7%
FBS and 1% penicillin-streptomycin at 37"C, 5% CO2 with 3 media changes per week. For
culture on scaffolds, HAEC were trypsinized, resuspended at 1xi06 cells/mL in culture media
and pipetted evenly onto scaffolds at a density of -3.6x10 4 cells/cm 2. Scaffolds were incubated
for 3 hours at 37 0C, transferred to 30mL polypropylene tubes with 6mL of culture media and
incubated at 37 0C, 5% CO 2. For experiments requiring free cells, cells were recovered by
digestion in collagenase IV in 1:1 ECGM2:PBS at 37C. After gelatin scaffolds were completely
digested, cells were recovered by centrifuging.
Preparation of Scaffolds for Staining
Scaffolds were cultured for the desired period of time, rinsed with PBS and fixed with
4% paraformaldehyde overnight at 40 C. All subsequent steps were carried out on ice or at 40C.
Following fixation, scaffolds were washed 3x 5 minutes with PBS followed by a 10 minute
Page 56 of 139
incubation with 200mM glycine in PBS to quench remaining free aldehyde groups. Scaffolds
were again washed 3x 5 minutes with PBS and then transferred to ice cold 18% sucrose in PBS
for 3 hours, followed by ice cold 30% sucrose for an additional 3 hours. Scaffolds were then
washed thoroughly with PBS and flash frozen with liquid nitrogen.57 Sections with a thickness of
20-60pm were cut using a cryotome and captured on positively charged slides. (SuperFrost Plus,
VWR) Sections were stored at -80 0 C for up to 3 weeks before staining.
Actin and Immuno-staining
Slides were allowed to reach room temperature and a PAP pen (Electron Microscopy
Sciences) used to create a hydrophobic barrier around each section. Sections were washed twice
with PBS and then permeabilized with 0.2% Triton X-100 in PBS for 10 minutes. Sections were
blocked for 1 hour in 1% BSA + 20% goat serum in PBS. Cells were immediately incubated in
primary antibody to PCAM (1:50, mouse anti-porcine CD3 1, Serotec) in 1%BSA/PBS overnight
at 40C in a humidified chamber. Sections were then washed 3x five minutes with 1 %BSA/PBS
and incubated 1 hour in the dark at room temperature with a fluorescent secondary antibody
(Alexa 488 conjugated goat anti-mouse IgG, 1:75, Invitrogen) in 1%BSA/PBS. In some cases a
1:200 dilution of rhodamine phalloidin was added to the secondary antibody solution. Finally,
sections were washed 3x five minutes with PBS and coverslipped using a fade resistant mounting
medium containing DAPI, a blue fluorescent nuclear stain (Vectashield with DAPI, Vector).
Stained samples were stored in the dark at 40C until imaged.
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Imaging and Actin Quantification
Sections were imaged using a Perkin-Elmer spinning disk confocal microscope at 63X
magnification with an oil immersion lens. Samples were imaged at z-intervals of 1 pm. the
resulting z-stack was turned into a maximal intensity z-projection image using ImageJ software.
For quantification of actin staining intensity only, samples were imaged using a Zeiss LSM 510
confocal microscope at 40X magnification with a water immersion lens. After the creation of a z-
projection image, ImageJ was used to select only those areas of the image representing cells, and
the average pixel intensity of image quantified. The average of 10, 40x fields was used to
calculate actin intensity for each scaffold type.
Cell Growth
8mm diameter scaffold discs of each type were prepared and seeded with 2x10 4 HAEC.
Scaffolds were cultured for up to 28 days under normal conditions. On days 0, 2, 5, 8, 12, 16, 21
and 28, cells were recovered from 3 scaffolds of each type and counted using a Coulter Counter.
Cell number was plotted as a function of both time and modulus. Growth rate for each scaffold
type was determined to be the slope of the linear regression of the cell number vs. time curve
during the growth phase (days 5-2 1).
Conditioned Media Preparation
Endothelial cell conditioned media was prepared for use in assays of secreted factors and
for smooth muscle cell inhibition experiments. For non-immune assays, a low serum conditioned
media was prepared to reduce interference from factors contained in FBS. This conditioned
media was prepared by washing confluent, 12mm scaffolds with serum free medium for 3x 10
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minutes, followed by incubation in 3.5mL endothelial cell basal medium 2 (ECBM2, Promocell)
supplemented with 0.5% FBS and antibiotics for 24 hours. Conditioned medium was then
collected, centrifuged to remove any particulates, and the supernantant frozen at -80C until use.
Cells were recovered from scaffolds and counted using a Coulter Counter.
Assays of Growth Regulatory Factors
Endothelial cell secretion of several growth regulatory factors was examined. Low serum
conditioned media was assayed for TGF-P I, FGF2, and PDGF. All were measured using
colorometric ELISAs from R&D according to kit directions.
Glycosaminoglycan and Heparan Sulfate Proteoglycan Assay
The concentrations of sulfated glycosaminoglycans and heparan sulfate proteoglycans
(which have been implicated in the smooth muscle cell growth inhibition function of endothelial
cells) were measured using a DMB assay as described in Chapter 2.
Smooth Muscle Cell Inhibition
The effect of EC conditioned media on smooth muscle cell proliferation was measured
using a radioactive thymidine incorporation assay. Human aortic smooth muscle cells (HASMC)
were purchased from Promocell and cultured at 37C, 5% CO 2 in DMEM supplemented with 5%
calf serum (CS), penicillin-streptomycin (PS) and glutamine.
For inhibition experiments, HASMCs were sparsely seeded in 48 well plates, allowed to
attach overnight, washed twice with PBS, and then starved for 24 hours with DMEM
supplemented with 0.1% CS and PS. Following starvation, culture medium was replaced with
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either low serum endothelial cell conditioned medium (n = 3, in duplicate) or fresh
ECBM2+0.5% FBS+PS (n = 3, in duplicate) and all wells then adjusted to 5% total serum. After
24 hours, to measure proliferation, 3H-thymidine was added to each well to a concentration of
I ptCi/mL and the cells incubated an additional 6 hours. Cells were then washed 3x with ice cold
PBS followed by incubation with 10% trichloroacteic acid in PBS for 30 minutes at 4C. Cells
were washed 2x with 95% ethanol and solubilized with 0.1% SDS in 0.25N NaOH. The lysate
was transferred to scintillation vials with UltimaGold LSC cocktail and 3H-thymidine
incorporation measured using a liquid scintillation counter and QuantaSmart software. Results
were expressed as a percent decrease in 3H-thymidine incorporation vs. control medium, either
per scaffold or normalized to endothelial cell number.
Integrin and Extracellular Matrix Gene Expression
The effect of the substrate modulus on cell attachment, gene expression of various
adhesions molecules (integrins) and extracellular matrix proteins was examined. After 12 or 21
days of culture, 49.9Pa, 173Pa and 1345Pa scaffolds were rinsed with PBS, flash frozen with
liquid nitrogen and cut into thin sections using a cryotome. Total RNA was extracted from the
cut scaffolds using an RNeasy Mini Kit with on column DNase treatment (Qiagen, Valencia,
CA) according to kit directions, except that the volume of lysis buffer was increased to I mL to
accommodate the volume of the scaffold. Complementary DNA was synthesized by reverse
transcription using the TaqMan reverse transcription reagents from Applied Biosystems (Foster
City, CA). Real-time PCR analysis was performed with an Opticon Real Time PCR Machine
(MJ Research, see Table 2 below for settings) using the SYBR Green PCR Master Mix Reagent
Kit (Applied Biosystems) and primers purchased from Invitrogen. (Table 3) Melting curves were
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done and examined to ensure that only the transcript of interest was amplified during the PCR
reaction, and only those genes with good melting curves were subsequently analyzed. Transcript
copy numbers were calculated from the C(t) value measured by the Opticon software.
Cycles Temperature Time
1 50 0C 2 min
1 95 0C 10 min
95 0C 15s
40 60 0C 1 min
Table 2: PCR Settings. These settings were used with the MJ Opticon PCR machine for RT-
PCR analysis of endothelial cell gene expression.
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Gene Forward (5' + 3') Reverse (5' 4 3')
GAPDH GGCCTCCAAGGAGTAAGACC AGGGGTCTACATGGCAACTG
ITGA5 GTCGGG GGCTTCAACTTA GAC CCTGGCTGGCTGGTATTAGC
ITGA6 GTTTTGTTTCCTCCCCTATCTGTAT GCTCCCCATATAACTTAACATTGTG
ITGAV AACTCAAGCAAAAGGGAGCA GGGTTGCAAGCCTGTTGTAT
ITGB1 AATGGGAACAACGAGGTCATGGTT TTGTGGGATTTGCACGG CAGTAC
ITGB2 GATGGTGAAGACCTACGAGAAACT AGAAGGAGTCGTAGGTGACTTTCAG
ITGB3 CGTTACTGCCGTGACGAGATTG TGGTGATGAGGAGTTTCCAGATG
COL1Al CCTGGATGCCATCAAAGTCT AATCCATCGGTCATGCTCTC
COL3A1 GGGAACAACTTGATGGTGCT CCTCCTTCAACAGCTTCCTG
COL4A1 TGGTCCAAGAGGATTTCCAG TCATTGCCTTGCACGTAGAG
COL4A5 GTCCAGATGGATTGCAAGGT ACCTGAAGTGTTCCCTGTGG
COL4A6 CCAGCTGCTCACAGAACAGA AGGCACAACGTAACCAGGAG
LAMI GAACAGTGTGTGGTGGATGC GGATGCTTAGCTCAACCGAG
FNl CCCAACTGGCATTGACTTTT CTCGAGGTCTCCCACTGAAG
HSPG2 ATTCAGGGGAGTACGTGTGC TAAGCTGCCTCCACGCTTAT
BIGLYCAN GGACTCTGTCACACCCACCT AGCTCGGAGATGTCGTTGTT
Elastin CAGTTGGTACCCAAGCACCT AGGTGGCTATTCCCAGTGTG
Fibrillin GTGACTGCCCACCTGATTTT AGCAGGAAGCTTTGGAAACA
MMP9 TTGACAGCGACAAGAAGTGG ACATAGGGTACATGAGCGCC
MMP2 AACGGACAAAGAGTTGGCAG GTAGTTGGCCACATCTGGGT
TIMP1 GGAATGCACAGTGTTTCCCT GAAGCCCTTTTCAGAGCCTT
TIMP2 TGATCCACACACGTTGGTCT TTTGAGTTGCTTGCAGGATG
~ IT'1~ i f A 'T' A A A e'~~ A A A A A ~/CI m m ~ c imA I~~~ A frmrMTI-MMP TGTACCAAACC CCTTCCCTCGTAGCAGT
Table 3: PCR Primers. All primers were designed with Primer3 and purchased from Invitrogen.
Integrin Flow Cytometry
Two important endothelial cell integrins, aOfP3 and as (found as 04p1 in endothelial cells)
were measured using flow cytometry to see how substrate modulus affects their expression.
Endothelial cells were grown on the full range of scaffolds until confluence and the cells
recovered by collagenase treatment. These cells were washed 2x with ice cold PBS + 2% heat
inactivated FBS + 0.09% sodium azide (Cell Staining Buffer, BD). 3x1 05 cells from each sample
were resuspended in 1 00ul of staining buffer and the appropriate volume of FITC conjugated
antibody (mouse anti-human integrin Cas or mouse anti-human integrin aVp3). After briefly
vortexing to mix, cells were incubated on ice for 45 minutes in the dark with shaking. Cells were
then centrifuged and washed 2x with ice cold staining buffer to remove excess antibody. Finally,
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cells were resuspended in 500pil of 1% paraformaldehyde in PBS. 104 cells were analyzed by
flow cytometry using a FACScalibur intstrument and CellQuest software (Becton Dickinson, San
Diego, CA). All samples were compared to similarly prepared cells stained with the appropriate
FITC conjugated isotype controls.
Statistics
Statistical analyses were performed with Prism (GraphPad) or Excel (Microsoft)
software. Data are expressed as mean +/- SEM unless noted. Comparisons between groups were
made by ANOVA followed by Tukey's multiple comparison test. A value of p < 0.05 was
considered statistically significant.
RESULTS
Scaffold Mechanical Properties are Related to Treatment
Three different methods were examined to alter the mechanical properties of Gelfoam.
The first method, heat treatment, yielded only small changes in compressive modulus of
Gelfoam. (Figure 20) Non-heat treated Gelfoam had a modulus of 297.1 +/- 21.9 Pa. Gelfoam
treated for 6 hours at 145C had a modulus of 348.7 +/- 6.9 Pa. Gelfoam treated for 24 hours at
145C had a modulus of 358.9 +/- 16.9 Pa. There was a maximal difference of only ~20% with 24
hours of heat treatment, likely due to the fact that the heat used to cross-link the Gelfoam was
already close to saturation prior to treatment.
The second method used to alter the mechanical properties of Gelfoam was crosslinking
using a carbodiimide solution. (Figure 21) With this treatment method, scaffold modulus was
dependent on crosslinker concentration (p < 0.0001 by ANOVA). Unmodified Gelfoam had a
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hydrated modulus of 173 +/- 5.9Pa which could increased to 1345 +/- 34.5Pa by treatment with
54.0/22.0 EDAC/NHS mM solution. This is a nearly eight fold increase in modulus over the base
scaffold - a much larger range than provided by heat treatment. Additionally, the increase in
scaffold modulus with EDAC/NHS treatment was linearly related (r2=0.98) to the concentration
of cross-linker used, allowing easy creation of scaffolds with a desired modulus. (Figure 22)
The final method used to alter the modulus of Gelfoam involving autoclaving matrices to
break protein-protein bonds and reduce scaffold stiffness. (Figure 21) Ten minutes of
autoclaving was sufficient to reduce the modulus of Gelfoam from 173 +/- 5.9Pa to 68.7 +/- 12.9
Pa. Twenty minutes of autoclaving further reduced the modulus to 49.9 +/- 16.7 Pa - a -71%
reduction in modulus from the base material. It should be noted that scaffolds autoclaved for 20
minutes are extremely fragile and easily damaged even with normal handling.
By using the carbodiimide and autoclaving methods, it was possible to create a set of
scaffolds with a 26 fold difference in modulus between the softest and stiffest scaffolds.
Page 64 of 139
400 -
300 -
200
0
100
0
OHr 6Hr 24Hr
Length of Heat Treatment (145C)
Figure 20: Effect of Heat Treatment on Gelfoam Scaffold Modulus. Although heat treatment
offered tight control over scaffold modulus, only small absolute (and relative) changes were able
to be achieved.
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Figure 21: Effect of Autoclaving and Carbodiimide Crosslinking on Gelfoam Scaffold
Modulus. By combining autoclaving and crosslinking methods, a 26x difference in modulus
between softest and stiffest scaffolds was obtained. Deformation rate = 0.01 mm/s. p < 0.0001 by
ANOVA.
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Figure 22: Scaffold Modulus is Linearly Related to Crosslinker Concentration. EDAC
concentration is directly related to scaffold modulus (r2 = 0.98), allowing the easy creation of
scaffolds of any modulus within this range. (Note that the ratio EDAC:NHS stays constant
through all treatments.)
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Endothelial cells on scaffolds have normal morphology and can be visualized using confocal
imaging techniques.
Endothelial cells on scaffolds were prepared for confocal imaging by fixing,
cryoprotecting, flash freezing, sectioning and immunostaining. Using this multi-step technique, it
was possible to directly image cells within the scaffold. PECAM antibody staining revealed
colonies of endothelial cells in cobblestone-like patterns within scaffolds. (Figure 23) Although
cells reached a quiescent state, as seen by the cessation of cell proliferation after day 21, they did
not populate all available surfaces within the scaffold, instead forming islands of cells, not all of
which were interconnected. These islands were found throughout the scaffold, but were much
more extensive along the periphery of the scaffold, where cell networks tended to be much larger
than in the interior of the scaffold. Cells grew on both the flat surfaces of pore walls and wrapped
around thinner struts. Images below show cells on 49.9Pa and 1345Pa scaffolds.
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Figure 23: Endothelial Cells in Scaffolds Grow in a Normal Cobblestone Pattern.
Endothelial cells in 49.9Pa (A,B) and 1345Pa (C,D) scaffolds expressed a normal cobblestone
morphology with PCAM expressed at their edges. Cells can be seen growing in relatively flat
islands (B,C) as well as wrapped around pore walls and struts (A,D). Stress fibers are visible in
most cells, regardless of the scaffold modulus.
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Actin cytoskeleton is similar across scaffolds.
Actin intensity was quantified in 10 40x fields for 49.9Pa and 1345Pa scaffolds. Some
qualitative differences were seen in endothelial cells on different matrices. Some cells on 1345Pa
scaffolds appeared to have more stress fibers than cells on 49.9Pa scaffolds, although both cell
types had prominent stress fibers. (Figure 23) However, when total actin was quantified, average
pixel intensity per area within each rhodamine phalloidin stained cell, the overall level of actin
was identical between the two types of scaffolds. (Figure 24) Rhodamine phalloidin stains
filamentous actin only, and staining is brighter when larger stress fibers are present. That the
intensity of staining was the same on both scaffold moduli suggests that their cytoskeletons were
similar.
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Figure 24: Average Brightness of Rhodamine Phalloidin Stained Cells is Independent of
Scaffold Type. The average pixel intensity of actin staining with cells was measured and
unchanged between 49.9Pa and 1345Pa scaffolds. (p = 0.985)
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Endothelial Cell Growth Rate and Cell Number is Affected by Scaffold Modulus
Endothelial cells proliferated and reached confluence in all scaffolds by ~21 days. (p =
NS for difference between cell numbers on day 21 and day 28 by t-test for all scaffold types.) In
all scaffolds, cell number began to increase slowly between days 2-5. (Figure 25) Cell number at
confluence (day 21) was dependent on modulus (p < 0.0004 by ANOVA). Cell number was
highest on scaffolds of 508Pa, with a 831.9 +/- 0.116 x10 3 cells. Cell number decreased at both
higher and lower scaffold moduli, reaching 387.5 +/- 1.194 x, 03 cells on 49.9Pa scaffolds, and
518.0 +/- 0.127 x, 03 cells on 1345Pa scaffolds. (Figure 26) The large error bars on the 49.9Pa
scaffold cell number can likely be attributed to the fragility of the scaffolds -just the act of
removing the scaffold from media to count cells was enough to damage the scaffolds in some
cases, causing error in the measurements.
By day 5, growth rate (Figure 27) became nearly linear, and could be approximated by a
straight line for all scaffolds. Growth rate was dependent on scaffold modulus (p <0.0001 by
ANOVA) and followed a similar pattern to cell number, with 0.297 +/- 0.014 x10 3 cells per day,
0.469 +/- 0.033 x10 3 cells per day, and 0.264 +/- 0.051 x10 3 cells per day on scaffolds of
1345Pa, 508Pa, and 49.9Pa respectively. All pairs of cell growth rate were statistically different
(p < 0.05 by Tukey's post test) except for 173Pa vs. 68.7Pa and 508Pa vs. 376.3Pa.
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Figure 25: Cell Number vs. Days Growth. Cell number begins to increase between days 2-5
for all scaffolds. Rate of cell growth increases around day 5 and becomes nearly linear through
day 21 for most scaffold types. Cell number plateaus around day 21 for all scaffolds.
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Figure 26: Cell Number Versus Modulus. Each line represents a different time point (labeled
with days of culture next to each line). Cell numbers at day 21 and 28 are not statistically
different. Maximum cell number is reached on 508Pa scaffolds.
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Figure 27: Growth Rate is Dependent on Scaffold Modulus. (p < 0.0001) Growth rate,
calculated as the slope of the growth curve between days 5-21, peaked at 508Pa. All pairs of
rates are statistically difference (p < 0.05 by Tukey's post test) except 173Pa vs. 68.7Pa and
508Pa vs. 376.3Pa.
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Secretion of Growth Factors
TGF-p1 in conditioned media was measured using a colorometric ELISA kit and
normalized to cell number. (Figure 28) TGF-bl levels ranged from 2289 +/- 123 pg/I 06 cells on
1345Pa scaffolds up to 2826 +/- 184 pg/10 6 cells on 376Pa scaffolds. The differences were
relatively small, and the differences between scaffolds were not significant. (p = 0.795 by
ANOVA), indicating that scaffold modulus did not effect its secretion. In fact, the total TGF-P1
secreted by each scaffold was linearly related to cell number in the scaffold (r2 = 0.948). (Figure
28)
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Figure 28: TGF-s1 versus modulus and cell number. Top: TGF-bl secretion is not affected
by scaffold modulus. Differences in TGF-bl secretion were small and not significant (p = 0.878
by ANOVA) Bottom: Total TGF-bl secreted by each scaffold is linearly related to cell number.
(r2 = 0.948)
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FGF2 in conditioned media was measured using a colorometric ELISA kit and
normalized to cell number. (Figure 29) FGF2 levels ranged from 228.0 +/- 34.9 pg/10 6 cells on
68.7Pa scaffolds up to 363.9 +/- 7.6 pg/10 6 cells on 1062Pa scaffolds. The differences were
relatively small but were statistically significant. (p = 0.005 by ANOVA), indicating that scaffold
modulus does effect its secretion. A parabolic curve was able to be fit to the data with an r2
0.77.
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Figure 29: FGF2 Secretion is Dependent on Scaffold Modulus. FGF2 significantly varies
with modulus (p = 0.005 by ANOVA). A parabolic curve can be fit to the data with r2=0.767.
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PDGF-BB in conditioned media was measured using a colorometric ELISA kit and
normalized to cell number. (Figure 30) PDGF-BB levels ranged from 122.3 +/- 8.6 pg/10 6 cells
on 173Pa scaffolds up to 229.7 +/- 12.0 pg/I 06 cells on 1062Pa scaffolds. The differences were
relatively small, but the differences between scaffolds were significant. (p = 0.01 by ANOVA),
indicating that scaffold modulus does effect its secretion. Although there were differences in
secretion between groups, there was no apparent correlation with scaffold modulus, and only one
pair of scaffolds is statistically different by Tukey's post test (1 73Pa and 1062Pa). In fact, the
dependence of PDGF-BB secretion on scaffold modulus is completely due to one point: 173Pa.
When this point is removed, ANOVA gives a value of p = 0.174 for differences between groups.
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Figure 30: PDGF-BB Secretion. PDGF-BB secretion is dependent on modulus (p 0.01 by
ANOVA). However, there does not appear to be any correlation between modulus and secretion,
and the dependence on modulus disappears if one point (*) is removed from the analysis.
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Heparan Sulfate Proteoglycan Secretion is Dependent on Modulus
Total sulfated glycosaminoglycan (GAG) and heparan sulfate proteoglycan (HSPG), a
sulfated glycosaminoglycan secreted by confluent endothelial cells, which inhibits the growth of
smooth muscle cells, was measured using a DMB assay. Both total GAG and HSPG secretion
were dependent on scaffold modulus (p < 0.0000 1 for GAG and p = 0.03 for HSPG, by
ANOVA). (Figure 31) Both GAG and HSPG followed the same general pattern, with the highest
levels found in the softest scaffolds (68.7Pa and 49.9Pa), with levels then decreasing and
plateauing. The maximum level of total GAG measured was in the 49.9Pa scaffold, at 10.6 +/-
1.2 jtg/10 6 cells, and the minimum level was 4.4 +/- 0.2 pg/10 6 cells at a modulus of 508Pa. The
maximum level of HSPG measured was 8.8 +/- 1.6 tg/l0 6 cells at 49.9Pa, and the minimum
level of HSPG was 4.6 +/- 0.4 tg/10 6 cells at 508Pa.
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Figure 31: GAG and HSPG Versus Modulus. Top: Total GAG was dependent on modulus (p
< 0.0001 by ANOVA). Secretion was highest at low moduli, and then dropped to a plateau.
Bottom: HSPG was also dependent on modulus (p = 0.03 by ANOVA). Again, secretion was
highest at low moduli, with a plateau starting around 173Pa.
Page 79 of 139
14-
200 400 600 800 1000
Modulus (Pa)
,
0
6
f
1400
12-
10 -
8
6-
4-
IIU:C.
(0 I
2
0
Smooth Muscle Cell Inhibition is Dependent on Modulus
Inhibition of smooth muscle cell proliferation by endothelial cell conditioned media was
measured using a 3H thymidine incorporation assay. The inhibition of smooth muscle cell
inhibition by endothelial cell conditioned medium (vs. control medium) was strongly dependent
on scaffold type, both when normalized to endothelial cell number (p < 0.0004) and when
expressed as inhibition per scaffold (p < 0.0006). (Figure 32)
When normalized to cell number (as a measure of the inhibitory potential of each cell
within the scaffold), inhibition is highest for the softest scaffold (97.5 +/- 22.1 % per 106 cells)
and drops with increased modulus, until a plateau is reached at -376Pa (32.2 +/- 2.8 % per 106
cells). The minimum inhibition is seen at 508Pa, with inhibition of 20.0 +/- 0.6 % per 106 cells.
The inhibition curve can be approximated by a power curve with an r2 = 0.79. These data
indicate that the inhibitory potential of cells is highest at low moduli, and then decreases until a
plateau is reached at higher moduli.
These data correlate well with the HSPG secretion data presented earlier. There is a linear
relationship between HSPG secretion and smooth muscle cell proliferation inhibition normalized
to cell number (r2 = 0.799). (Figure 33) This correlation becomes even stronger (r2 = 0.933) if the
common "plateau" region of inhibition and HSPG secretion (I062Pa and 1345Pa) is removed
from the analysis, suggesting that at high moduli, factors other than HSPG may play a role in the
inhibitory potential of endothelial cells.
When data are expressed as decrease in smooth muscle 3H-thymidine incorporation per
scaffold, inhibition peaks at an intermediate modulus of 173Pa, with 51.8% +/- 3.6% inhibition.
Inhibition then dropped off at both higher and lower moduli, reaching a low of 21.2 +/- 0.8% at a
modulus of 1345Pa.
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Figure 32: Smooth Muscle Cell Inhibition Versus Modulus. Top: Inhibition normalized to
endothelial cell number. Inhibition at low modulus appears to be modulus dependent, while it is
modulus independent at higher moduli. Bottom: Inhibition per scaffold (not normalized to cell
number). Maximal inhibition occurs at an intermediate modulus, 173Pa, and drops off at both
lower and higher moduli.
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Factor Function Shape of Fit Peak
Cell Number at 5951Pa
Confluence
Growth Rate 517Pa
TGF-P1 Modulates growth and ECM N/A
deposition
FGF2 Induces cell growth 816Pa
PDGF-BB Induces cell growth N/A
HSPG Inhibits smooth muscle cell 50Pa
growth
Normalized SMC In vivo, ECs inhibit SMC 50Pa
Inhibition proliferation, preventing
Non-Normalized intimal hyperpnasia 173Pa
SMC nhibtion (overproliferation of SMC
into vessel lumen)
Table 4: Summary of Cell Growth and Secretion Data From Chapter 3. Peak refers
to the peak of the curve fit to the relevant data unless it occurs at the end of the range of
modulus (i.e. 5OPa or 1345Pa).
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Extracellular Matrix Protein Gene Expression is a Function of Modulus and Changes
with Confluence.
To determine if the mechanism by which functional changes are induced in
endothelial cells is related to changes in the cell-substrate interface, expression of
extracellular matrix genes was examined using RT-PCR. Gene expression was examined
at 12 days, before cells reached confluence, and at 21 days, after confluence was reached.
At both time points some extracellular matrix genes were differentially expressed on
different scaffold types. Only three scaffold moduli were used in this set of experiments:
49.9Pa, 173Pa and 1345Pa. All data for each gene were normalized to the average 49.9Pa
scaffold expression for that gene. N = 6 for all. Data was analyzed by ANOVA followed
by Tukey's post test. A value of p <0.05 was considered significant. Versican, decorin,
MMP9 and tenascin data were not used in analysis, as the melting curves for these
primers showed multiple peaks.
Analysis of day 12 RT-PCR data showed that there were small (generally a
change of less than 50% of the value of 173Pa scaffold expression) but statistically
significant differences in the expression of some extracellular matrix genes in endothelial
cells grown on scaffold of different moduli. The data are summarized in the graphs
below. Collagen, one of the major structural proteins of the endothelial extracellular
matrix, was differentially expressed on different scaffolds. Collagen IV, 00 (the most
abundant collagen in endothelial cell matrix) was expressed significantly more on 173Pa
scaffolds than on 49.9Pa or 1345Pa scaffolds. Collagen IV, aC5 was expressed statistically
significantly more on 173Pa scaffolds than on 49.9Pa scaffolds. Collagen III, aXl was
expressed statically significantly more on 173Pa scaffolds than on 1345Pa scaffolds. In
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general, collagens seem to be upregulated on 173Pa scaffolds compared to other scaffold
moduli. (Figure 34)
Other matrix protein genes were also differentially expressed. Expression of the
non-heparan sulfate proteoglycan core protein biglycan was statistically lower on 1345Pa
scaffolds than on 173Pa or 49.9Pa scaffolds. Fibrillin expression was statistically higher
on 1345Pa scaffolds than on 49.9Pa ones. Elastin, which would be expected to decrease
the stiffness (and therefore modulus) of a substrate, was expressed statistically
significantly more on 1345Pa scaffolds than either 49.9Pa scaffolds or 173Pa scaffolds.
This was the largest difference seen, with over a two-fold change between the two softer
scaffolds and the 1345Pa one. (Figure 35)
In addition to the matrix protein genes themselves, genes for enzymes which
control remodeling of the matrix were also affected. MMP2 expression was significantly
higher on 173Pa scaffolds than on 1345Pa scaffolds. TIMP2 expression was significantly
higher on 173Pa scaffolds than on either 49.9Pa or 1345Pa scaffolds. And MT1 -MMP
expression was higher on 173Pa scaffolds than on 49.9Pa scaffolds. These data suggest
than extracellular matrix turnover was occurring more on 173Pa scaffolds than on the
49.9Pa or 1345Pa scaffolds, which corresponds to the growth rates measured for these
scaffold types. (Matrix turnover would be expected to increase as cell proliferation
increased.) (Figure 36)
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Figure 34: Collagen Gene Expression Is Altered With Scaffold Stiffness at Day 12.
Expression of collagen IV al, collagen IV a5, and collagen III c*I were all affected by
scaffold modulus. Expression was measured by RT-PCR. n = 6 for all. Data analyzed by
ANOVA followed by Tukey's post test.
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Figure 35: Other Extracellular Matrix Genes Were Affected By Scaffold Stiffness,
As Well. Biglycan was down regulated on 1345Pa scaffolds, while elastin was up
regulated. Fibrillin was higher on 1345Pa scaffolds compared to on 49.9Pa ones.
Expression was measured by RT-PCR. n = 6 for all. Data analyzed by ANOVA followed
by Tukey's post test.
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Figure 36: Genes Controling Matrix Remodeling Are Affected By Scaffold Modulus.
MT1 -MMP, MMP2, and TIMP2 were all upregulated on 173Pa scaffolds. This follows
the pattern of cell growth rate. Expression was measured by RT-PCR. n = 6 for all. Data
analyzed by ANOVA followed by Tukey's post test.
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Analysis of day 21 (confluence) RT-PCR data showed that there were small but
statistically significant differences in the expression of some extracellular matrix genes in
endothelial cells grown on scaffolds of different moduli (Figures 37-39 below). Some
collagens were differentially expressed on different scaffolds. Collagen IV, al and
collagen IV, a5 were expressed statistically significantly more on 49.9Pa scaffolds than
on 1345Pa scaffolds. (Figure 37) Fibronectin expression was statistically higher on
49.9Pa scaffolds than on either 173Pa or 1345Pa scaffolds. Perlecan, a proteoglycan
normally attached to heparan sulfate, was expressed at higher levels on 49.9Pa scaffolds
than on 173Pa or 1345Pa scaffolds. Biglycan was statistically significantly upregulated
on 49.9Pa scaffolds compared to 134Pa scaffolds. Elastin expression was statistically
significantly higher on 1345Pa scaffolds compared to on 173Pa. (Like with subconfluent
scaffolds, this was the largest fold change seen.) Finally, fibrillin was down regulated
statistically significantly on 1345Pa scaffolds compared to 49.9Pa ones. (Figure 38)
Genes for proteins involved in matrix remodeling were also affected by scaffold
modulus. TIMPI and TIMP2 were both upregulated statistically significantly on 1345Pa
scaffolds compared to 173Pa scaffolds, and TIMP2 was also upregulated on 1345Pa
scaffolds compared to 49.9Pa ones. (Figure 39)
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Figure 37: Collagen Gene Expression Is Altered With Scaffold Stiffness at Day 21.
Expression of collagen IV ctl and collagen IV ci5 were up regulated on 49.9Pa scaffolds
compared to 1345Pa ones. Expression was measured by RT-PCR. n = 6 for all. Data
analyzed by ANOVA followed by Tukey's post test.
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Figure 38: Other Extracellular Matrix Genes Were Affected By Scaffold Stiffness,
As Well. Fibronectin, perlecan and biglycan were down regulated on stiffer (1 73Pa,
1345Pa) scaffolds, while elastin was up regulated on 1345Pa scaffolds. Fibrillin was
higher on 49.9Pa scaffolds when compared to on 1345Pa ones. Expression was measured
by RT-PCR. n = 6 for all. Data analyzed by ANOVA followed by Tukey's post test.
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Figure 39: TIMP Expression Is Affected By Scaffold Modulus. TIMPI and TIMP2
were upregulated on 1345Pa scaffolds compared to softer ones. MT1-MMP and MMP2
were not effected. Expression was measured by RT-PCR. n = 6 for all. Data analyzed by
ANOVA followed by Tukey's post test.
Although there are statistically significant differences in expression of several
major extracellular matrix proteins, including collagen IV, fibronectin and perlecan,
between matrices of different moduli, the ratios of these proteins are largely unchanged.
(Figures 40-41 below) The ratios of the various collagen IV chains are not statistically
different. Similarly, the ratio of collagen IV cc to other common ECM proteins -
including fibronectin, laminin, biglycan and perlecan - is unchanged with scaffold
modulus. The ratios of fibronectin to biglycan, and collagen IV al to elastin and fibrillin
do change with scaffold modulus. Still, the ratios of the major constituents of the
extracellular matrix appear to be fairly consistent among scaffolds, meaning that while
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the amount of ECM is changing, its composition is similar. None of the scaffolds are
causing the cells to produce a grossly changed or pathologic ECM.
Matrix remodeling gene (MMP2, TIMP1, TIMP2, MTI-MMP) ratios are largely
statistically unaffected by scaffold modulus. However, the ratio of MMP2:TIMP2 was
statistically significantly lower on 1345Pa scaffolds than on 49.9Pa scaffolds. (Figure 42)
TIMP2 is capable of potentiating the activation of MMP2 by MTI-MMP as well as
inhibiting the active molecule. 58 The effect of the change in ratio of the two seen here on
MMP2 activation is unknown and depends on the actual concentrations of the molecules
around the cells. This data, together with the ECM gene ratio data, suggests that the cell
and its ECM secretory/remodeling mechanism is not being changed at afundamental
level, but that, rather, the changes are a matter of degree and level of stimulation.
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Figure 40: Ratio of Collagen IV Gene Expression to Other Major ECM Genes Is
Largely Unchanged With Scaffold Modulus. The expression ratios of the various
collagen IV chains is unchanged with scaffold modulus. The ratio of collagen IV cal to
other major extracellular matrix proteins is generally not statistically significant. The
exceptions are the ratio of Collagen IV al to fibrillin (173Pa > 1345Pa, p < 0.05) and
elastin (49.9Pa > 1345Pa, p < 0.01)
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Also Largely Unchanged by
Scaffold Modulus. The ratio of laminin gene expression to other ECM proteins is not
statistically significantly different with different scaffold moduli. The ratio of fibronectin
to perlecan is not statistically different on different moduli, but the ratio of fibronectin to
biglycan is statistically higher on 1345Pa scaffolds than on 49.9Pa scaffolds.
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Figure 42: Ratios of Matrix Remodeling Genes Are Largely Unaffected By Scaffold
Modulus. However, the ratio of MMP2:TIMP2 is statistically higher on 49.9Pa scaffolds
than on 1345Pa scaffolds. Depending on the concentration, TIMP2 can either inhibit
MMP2 or potentiate its activation by MTI MMP. 5s
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Integrin Expression is Dependent on Scaffold Modulus
Integrin gene expression at confluence was studied using RT-PCR. Cell surface
expression was studied using flow cytometry. Some types of integrins are down regulated
as substrate modulus increases, while others are not affected. RT-PCR was used to
examine gene expression in confluent endothelial cells of integrin subunits, X5, U6, Cav, Pi
and P3. (These are normally found complexed as a0 1, avP3 and (p13 in endothelial
cells.) (Figure 43) Subunit x5 was up regulated on 49.9Pa scaffolds compared to either
173Pa or 1345Pa scaffolds. Subunit P, was also upregulated on 49.9Pa scaffolds
compared to 1345Pa ones. Gene expression of other integrin subunits were not affected
by scaffold modulus.
In addition to RT-PCR, cell surface expression of integrins Cs and avf3 was
examined using flow cytometry. Like with RT-PCR, integrin expression generally
decreases as substrate modulus increases. a5 was expressed by 100% of cells, but the
level of expression decreased exponentially with increasing modulus (r 2 = 0.93) from a
high of 547 +/- 87.6 fluorescence units for 173Pa scaffolds to 252 +/- 1.4 fluorescence
units on 1345Pa scaffolds. (Figure 44) This drop was statistically significant (p < 0.001
by ANOVA). Expression of C4p3 also decreased with increasing modulus, but followed a
different pattern. (Figure 45) All cells which expressed cavP 3 did so at approximately the
same level, but the number of cells which expressed this integrin decreased slightly with
increased modulus. A maximum of 96.3 +/- 0.1% of cells expressed a3P3 at 68.7Pa, and
dropped to 79.3 +/- 1.6% of cells at 1345Pa. This drop was statistically significant by
ANOVA (p < 0.001). Tukey post analysis shows that the scaffolds can be divided into
two groups: scaffolds with moduli of 49.9-376Pa and scaffolds with moduli 508-1345Pa.
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Within each group, the percentage of aA3 positive cells is not statistically different, but
every pair between the two groups is (p < 0.05 by Tukey).
*E49.9Pa E173Pa
I
0 1345Pa
I
Integrin A5
# = 49.9Pa vs. 173Pa, p < 0.05
$ = 49.9Pa vs. 1345Pa, p < 0.05
T
Integrin A6
I
Integrin AV
T $ I
Integrin B1 Integrin B3
Figure 43: Integrin Gene Expression Is Affected By Scaffold Modulus: Integrin a5
expression is statistically higher on 49.9Pa scaffolds than on either 173Pa or 1345Pa
scaffolds. Integrin bI expression is higher on 49.9Pa scaffolds than on 1345Pa scaffolds.
Other integrins were not significantly affected.
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Figure 44: Integrin a5 Cell Surface Expression is Dependent on Modulus. All cells
express as integrin on their surface (Top), but the geometric mean of fluorescence
(Bottom) decreases with increased modulus (p < 0.001 by ANOVA, exponential fit r2
0.935).
Page 96 of 139
110 -
0o
0.
0
80
1000 1200 1400
0
0
0)
ir
E0
()
t5
R2 = 0.9354
R
800 1000 1200 1400
E
U
100 -
0
0
0.
a.
w-"
t30
200 400 600 800
Hydrated Modulus (Pa)
1000 1200 1400
f
ff
0 200 400 600 800
Modulus (Pa)
1000 1200 1400
Figure 45: avP3 Cell Surface Expression Depends on Modulus. The percentage of
cells which express avp3 (Top) can be divided into two groups: one at lower moduli, and
one at higher moduli. Fewer cells on scaffolds in the higher modulus group express avb3
compared to the lower modulus group. (p < 0.001 by ANOVA) Expression within each
group is not statistically different by Tukey. The average fluorescence of cells expressing
this integrin is the same regardless of scaffold modulus.
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DISCUSSION
Previous studies examining the effect of substrate rigidity on endothelial cell
function in three dimensional culture have focused mainly on cell morphology and
attachments. Tubulogenesis and focal adhesion formation are both affected. However, the
effect on cell functionality has not been closely examined. In this work, we have begun to
examine the effect of substrate modulus on the functionality of endothelial cells in 3D
culture, including such aspects as proliferation, integrin presentation, extracellular matrix
production and inhibition of smooth muscle cells.
The Young's modulus of an isotropic, porous structure (E*) depends on three
variables: the density of the scaffold (p*, a factor related to the physical structure of the
scaffold), the density of material from which the material is made (ps), and the modulus
of the material from which the scaffold is made (Es). These variables are related by the
equation 59
2
E, ps
If p* and ps are unchanged, the Young's modulus E* is linearly related to the modulus of
the scaffold material Es. Thus, the Young's modulus can be used as an easy to measure
surrogate for the modulus of the material on which the cells actually sit.
In this work, established techniques utilizing a carbodiimide cross-linker6 0 ,5 6 were
used modify a "base" scaffold (Gelfoam, a commercially available gelatin surgical
sponge) to have an increased, predictable modulus by adding crosslinks to the gelatin
substrate while retaining the same physical structure. Autoclaving broke down some of
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the protein crosslinks inherent in the base material, creating scaffolds with the same
physical structure which were softer than the base material. Between these two
techniques, it was possible to create a series of scaffolds with a 27-fold difference in
modulus and the same chemical and physical structure.
The modulus of the material on which the cells are sitting can also be estimated.
An AFM cantilever technique was used to measure the modulus of a single strut of a
hydrated "base" scaffold (1 73Pa bulk modulus) to be 4387 +/- 1072Pa. Due to technical
issues, only one strut was able to be measured - and only with a large degree of error -
and therefore was not included in this thesis, but this value allows us to estimate the
substrate material modulus for the complete range of Young's moduli used in this work,
since p* and ps were kept constant by the modification techniques used. Es for the range
of Young's moduli used in this work range from 1.27kPa to 34.1 kPa (for the 49.9Pa and
1345Pa scaffold respectively).
The range of substrate material moduli corresponds well with published in vivo
vessel values. Most of the reported mechanical values for blood vessels look at the vessel
as a whole, and the modulus of the endothelial cell extracellular matrix has not been
reported in the literature. However, the modulus of the vessel media (smooth muscle cell
layer), on top of which endothelial cells sit, as measured by AFM nanoindentation is in
the 5-8kPa range - close to the substrate material modulus for the 173Pa scaffold used
in this work.
Many diseases, including atherosclerosis, diabetes and hypertension, can increase
the stiffness (and modulus) of the vessel wall. Although most mechanical values reported
in the literature for these conditions are not directly comparable to those measured in this
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work, the high end of the range of the substrate material moduli approaches the moduli of
atherosclerotic plaques. Reported atherosclerotic plaque moduli span a huge range, from
33kPa up to 2.3MPa62, depending on many factors including the level of fibrosis of the
plaque and the method of measurement used.
The techniques used in this work to alter scaffold modulus allowed us to isolate
the effect of substrate modulus on cellular function. Additionally, the range of substrate
material moduli were estimated to be in a physiologically relevant range, with the 173Pa
scaffold in the same range as a normal artery, and the stiffest scaffolds approaching the
modulus of an atherosclerotic plaque.
In this study, proliferation of endothelial cells was strongly dependent (p<0.0001)
on scaffold modulus. Growth rate was highest on scaffolds of intermediate modulus
(508Pa), and dropped off significantly at high or low moduli. Total cell number at
confluence (21 days) follows the same general pattern as growth rate. It should be noted
that the softest scaffolds studied (49.9Pa) were extremely difficult to handle without
damage, possibly adding to the sharp drop off in growth rate and cell number between the
two softest substrates. These results suggest that there is an optimal stiffness for the
proliferation of endothelial cells in 3D culture. This is somewhat different than what has
been reported in the literature for other cell types. In 2D, many cell types, including
fibroblasts' 8 and smooth muscle cells1 9, proliferate more quickly on stiffer substrates
compared to softer ones, although adult neural stem cells proliferate best on substrates of
intermediate modulus.6 3 Less has been reported about proliferation in 3D, but
chondrocytes are either not affected by modulus54 , or proliferate better on stiff
scaffolds60,17. Similarly, fibroblasts in 3D culture proliferate better on stiff substrates64
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This suggests that endothelial cells may respond differently to modulus than other cell
types, that their "ideal" range of substrate stiffness is narrower, or that determination of
"ideal" scaffold modulus is strongly dependent on the range of moduli investigated.
In addition to cell proliferation, the secretory function of endothelial cells was
also examined. Endothelial cells normally secrete a wide variety of growth and regulatory
factors. These include the growth factors TGF-1, FGF2, and PDGF-BB, which were
examined here. All three growth factors are affected by scaffold modulus in a slightly
different way. PDGF-BB and FGF2 were dependent on modulus. For PDGF-BB,
however, only one pair of scaffolds was statistically different for PDGF-BB (I 73Pa of
1062Pa), and there was no correlation between scaffold modulus and PDGF-BB. FGF2
was also dependent on scaffold modulus by ANOVA. However, in this case, there was a
fairly good correlation between FGF2 and modulus, which followed the same general
pattern as growth rate and cell number (an inverse parabolic curve, with a maximum at
intermediate moduli). TGF-p1 was independent of scaffold modulus. It should be noted,
however, that only total TGF-P3 was measured, not activated TGF-pl. It is possible that
even when total protein is not affected, TGF-P activation is. It is noted in the literature
that mechanical strain, which can be though of as analogous to the changes in the cells
mechanical environment in our system, can change TGF-P activation without changing
total levels."
In addition to examining growth factor secretion, the secretion of heparan sulfate
proteoglycans was also measured. HSPGs, which are a subset of total sulfated
proteoglycans, are necessary for endothelial cell mediated inhibition of vascular smooth
2
muscle cell proliferation. HSPG secretion was dependent on scaffold modulus.
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Secretion was highest at 49.9Pa, and then decreased until a plateau was reached between
approximately 173Pa and 376Pa. The maximum HSPG secretion (per million cells) was
over twice that of the minimum, a difference which could be expected to be functionally
significant.
When used in vivo, matrix embedded endothelial cells exert their effect by
secretion of factors including HSPGs, into the vessel wall, which inhibits the growth of
smooth muscle cells, preventing neointimal hyperplasia. To test whether the differences
in growth factor and HSPG secretion with scaffold modulus are functionally significant,
endothelial cell conditioned media ability to inhibit smooth muscle cell growth was
measured using a 3H thymidine incorporation assay. 3H thymidine incorporation was
normalized to endothelial cell number, yielding a measure of the inhibitory potential of
individual cells. Inhibition was seen to decrease linearly. As with growth rate, the error
induced by the fragility of the E=49.9Pa scaffolds must be taken into account when
analyzing its cell number normalized inhibition, but r2 = 0.98 between 69-508Pa, with an
increase in modulus, until a plateau was reached with the stiffest scaffolds (E >= 508Pa).
It is interesting to note that the pattern of smooth muscle cell inhibition closely
follows the pattern of HSPG secretion. However, HSPG secretion plateaus at lower
modulus than smooth muscle cell inhibition. This difference may be explained by looking
at FGF secretion as a promoter in addition to HSPG secretion as an inhibitor of smooth
muscle cell proliferation. FGF2 secretion is increased at high moduli compared to very
low moduli. (<=69Pa) This means that at high scaffold modulus, endothelial cells are
secreting not only less inhibitory HSPGs, but also more stimulatory FGF2, further
decreasing their inhibitory potential.
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Clinically, the inhibitory ability of individual cells is less important than the
inhibition caused by the scaffold as a whole. When analyzing the inhibition caused by the
scaffolds as a whole, inhibition increases gradually as stiffness decreases, then plateaus
and then finally drops sharply with the softest scaffolds. This pattern is similar to, but
offset from, the pattern of growth rate.
These data suggest that modulus affects the inhibitory potential of the embedded
endothelial cells in two distinct ways. The first is simply a mass effect. The modulus
controls the number of endothelial cells able that can colonize each scaffold, and
therefore the mass of inhibitory HSPGs produced by the construct as a whole. The second
is an effect on the individual cells. Cells on softer scaffolds have an inhibitory potential,
which is clearly higher than that of cells on stiff scaffolds, caused by both increased
HSPGs and decreased FGF2. Together, these two effects combine to produce a range of
moduli where actual inhibition plateaus. It is interesting to note that Gelfoam, the base
material here that has been used for previous in vivo experiments3 2 34 , falls in the middle
of this plateau, suggesting that no optimization of the scaffold may be needed for
maximal effectiveness in vivo.
Even though the underlying substrate provides the physical support for cell
growth, the cells do not interact directly with it. Instead, cells sit on extracellular matrix
that they themselves produce. To determine if changes in this cell-matrix-substrate
interface correlate with our functional data, extracellular matrix production was
examined. Different ECM gene expression patterns were found in subconfluent cells
compared to confluent cells. In subconfluent cells only a few ECM protein genes were
affected by scaffold modulus. Specifically, collagen IV expression was higher on 173Pa
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scaffolds than on either 50Pa or 1345Pa scaffolds. Similarly, matrix remodeling genes
MTI-MMP, MMP2 and TIMP2 were all expressed at a higher level on 173Pa scaffolds
than on 50Pa or 1345Pa scaffolds. This correlates with cell growth rate, and it is expected
that more proliferatory cells would show increased remodeling of their environment.
In confluent cells, our data show that endothelial cells on softer scaffolds produce
significantly more of several common, key ECM molecules, including the cc and cX
chains of collagen IV, fibronectin, biglycan and perlecan, than cells on stiffer scaffolds.
However, the ratios between these molecules is similar between types of scaffolds,
suggesting that while the cells on softer scaffolds are producing more matrix than those
on stiffer scaffolds, the ECM itself is similar. One ECM gene which did not follow this
pattern was elastin, which was expressed at higher levels on the stiff substrate versus
softer ones, in both confluent and subconfluent cells.
Unlike ECM protein genes, matrix remodeling genes (specifically TIMPI and
TIMP2) were expressed at higher levels on both 50Pa and 1345Pa scaffolds than on
173Pa scaffolds. The remodeling data taken together with the ECM protein data suggest
that it is possible confluent endothelial cells on softer scaffolds may be trying to stiffen
their substrate by producing more structural ECM proteins, while cells on stiffer matrices
may be trying to achieve the opposite affect by producing more elastin - a molecule
which would increase the compliance of their substrate.
Substrate dependent ECM production is found across cell types. Extracellular
matrix formation in various cell types is dependent on the material on which they sit. For
example, fibroblasts5 and embryonic stem cells 65 produce different ECM when cultured
in 2D vs. 3D. Chondrocyte ECM production changes with alterations in 3D structure 50
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and with substrate stiffness 54 . Fibroblasts and endothelial cell differentially remodel their
ECM in 2D when cultured on substrates of varying stiffness.12 Finally, endothelial cells
in vivo differentially express genes for ECM molecules depending on the stiffness of the
31
artery from which they came.
The type of extracellular matrix changes seen in our system - an increase in the
overall amount of ECM but few changes in its composition - suggests that the endothelial
cells are not being changed on a fundamental level. The type of extracellular matrix
produced by endothelial cells corresponds with their functional state. For example, an
extracellular matrix rich in laminin will promote quiescence compared to one rich in
collagen 1, which promotes angiogenesis.66 Similarly, tumor endothelial cells, which are
highly dysfunctional, produce excess collagen I and III. 66 The fact that the extracellular
matrix produced by our endothelial cells is compositionally similar suggests that their
base functionality has not changed.
In addition to extracellular matrix, integrins - the interface between the cell and
the matrix - were examined as well. Two types of integrins were examined in this thesis:
oCaP3 and CasP1. The main target of both of these integrins is fibronectin, one of the ECM
proteins most affected by stiffness, although both bind to other molecules as well. avP3
also binds to vitronectin. It also binds to VEGFR2, and increases the action of VEGF-A.
a4i binds to Tie2 and potentiates the action of angiopoietin, which is involved in the
maturation of blood vessels . CavP3 is generally found in immature focal complexes such
as those found on migrating cells, while Casp tends to be found in the more mature focal
adhesions (which contain proteins such as vinculin, etc. in addition to integrins).67 Both
are involved in angiogenesis, but at different stages. avP3 is found on proliferating cells
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actively forming vessels and is involved in the prevention of apoptosis, while L5fP1 is
associated with the maturation of new blood vessels (a more quiescent phenotype) and is
also found in quiescent EC. 68,69 This is not an either/or situation, however, and
angiogenic cells can express both types of integrins at the same time.
The Cs1 integrin, was expressed less in cells grown on stiff substrates compared
to softer substrates. This was seen both at the gene expression level by RT-PCR data as
well as by flow cytometry. The xv03 integrin, also a fibronectin receptor, was also
affected, though in a different way. Unlike the a 5 p1 integrin, gene expression of avp3 was
not significantly different between scaffolds. Also, with integrin 1A3p, all cells expressed
some amount of the integrin but the level of surface expression (as measured by the
geometric mean of fluorescence recorded by flow cytometry) varied between groups.
Integrin avb3 appeared to he regulated in more ofan on/off fashion All rels which
expressed the protein exhibited similar levels of surface presentation, but the proportion
of cells expressing this integrin varied with stiffness.
The integrin expression results seen in this study differ from the results seen for
other cell types in the literature. Most studies examining the effect of substrate modulus
on integrin and/or focal adhesion expression reported that cells on stiffer substrates tend
to produce more of these molecules. 15 ,8 ,2 1 It is possible that in our system, the effect of
remodeling, in the form of ECM production, outweighs the effect of substrate modulus
itself in affecting integrin expression.
Changes in extracellular matrix gene expression correlate well with changes in
smooth muscle cell inhibition. Gene expression of many extracellular matrix proteins,
including collagen IV oa 1, collagen IV a5, fibronectin, and perlecan, the major core
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protein for HSPGs in endothelial cells, was linearly correlated to smooth muscle cell
inhibition. Although these correlations only involved three points, the fits were excellent,
with r2>=0.95. These strong correlations suggest that scaffold modulus may regulate
extracellular matrix production and smooth muscle cell inhibition through the same
pathways.
Integrin expression and smooth muscle cell inhibition correlate in interesting
ways. Integrin CA3 appears to correlate with smooth muscle cell inhibition, but integrin
cfAi expression levels are especially strongly related to smooth muscle cell inhibition.
There is a linear relationship between both U5 and Pi integrin gene expression and smooth
muscle cell inhibition (r 2 > 0.99 for both). Additionally, when the cell surface expression
levels of a5 integrin are plotted versus smooth muscle cell inhibition or HSPG secretion,
an interesting pattern appears. At the low integrin expression levels of high modulus
scaffolds, inhibition is flat. However, once integrin expression has reached its maximum
and plateaus at low moduli (<= 173Pa), both inhibition and HSPG secretion begin to
increase. (Figure 46) It is should be noted that this region of increasing HSPG secretion
and smooth muscle inhibition correlates with the mechanically sensitive region of the
HSPG/smooth muscle inhibition versus modulus curves as well.
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Figure 45: Smooth Muscle Cell Inhibition Correlates with Integrin a43 1 Expression.
Top: Integrin cC (Left) and Pi (Right) subunit gene expression strongly correlates with
cell number normalized smooth muscle cell inhibition. Bottom: Below a critical integrin
c5 surface expression, smooth muscle cell inhibition is independent of modulus.
Based on the data presented in this chapter, it is possible to propose the following
model for modulus control of endothelial cell function. In vivo endothelial cells are part
of both 2D and 3D structures - they line the interior of blood vessels in a 2D sheet, but
the vessels themselves course through tissues as 3D structures. The endothelial cells in
these 3D structures are subject to several types of mechanical forces and parameters -
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contraction and compression of the surrounding tissue, shear flow on the inside of the
vessel, and the modulus of the surrounding tissue and vessel wall. Normally, endothelial
cells are able to exist in their preferred, low energy state by producing a specific set of
extracellular matrix molecules and integrins to balance these forces. This balanced state
would also correspond to secretion of a specific level of inhibitory and stimulatory
molecules.
In our system this balance has been disturbed by changing the modulus of the
scaffold on which the cells sit. (In vivo the balance may be disturbed by the stiffening of
tumor stroma or the creation of areas of turbulent flow around atherosclerotic plaques, for
example.) In the proposed model (Figure 47), in response to the disturbance, cells attempt
to restore the balance of forces and their preferred basal state by altering their expression
of extracellular matrix and integrins. Changes in integrin number and composition alter
intracellular signaling and have downstream effects on cell function including changes in
secretion of both inhibitory and stimulatory factors. These changes in stimulatory and
inhibitory function are different and do not change in lockstep. Growth stimulatory
function (FGF2, PDGF-BB secretion) is largely conserved, while growth inhibitory
function (heparan sulfate secretion, smooth muscle inhibition) undergoes larger changes.
The magnitude of their change was related to the specific changes in integrin expression
caused by the change in modulus.
The two types of integrins examined in this thesis, afP3 and a5P 1 , are associated
with different cellular phenotypes. avP3 is only associated with a stimulated phenotype:
cells which are actively proliferating and migrating. X51PI on the other hand, can be
associated with a more stable phenotype: quiescent cells with stable focal adhesions.
67
-
69
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It is these stable, non-proliferating endothelial cells which produce growth inhibitors such
as heparan sulfates.
The actual changes in inhibitor and stimulator secretion were not linearly
correlated to integrin expression. Integrin mediated intracellular signaling is complex and
downstream functions can be affected by many factors, including signals from integrins
not studied in this work and autocrine/paracrine signaling. Rather, the magnitude of
integrin expression alteration corresponds to changes in secretion. In our system, x5fpi
expression alteration was much larger than change in aWP3 with change in modulus. In
turn, the inhibitory secretion associated with a stable, non-proliferating phenotype (like
that of a3p1 expressing cells) was affected more than secretion of growth factors, which
can be associated with a more activated, proliferative phenotype (such as that of c4P3
expressing cells).
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Figure 47: Proposed Model of Control of Cell Function By Substrate Modulus: Top:
Cells exist in balance with the forces of their environment, and express a specific set of
integrins and ECM, and have a given secretory function. Middle: Change in substrate
modulus upsets the balance. Bottom: In response, cells alter ECM and integrin
expression, which has differential downstream effects on growth inhibition and
stimulation based on the new complement of integrins.
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CONCLUSIONS
Utilizing carbodiimide crosslinked and autoclaved gelatin scaffolds, we isolated the
effect of modulus on endothelial cells cultured in 3D. Substrate rigidity affected
proliferation, growth factor secretion, extracellular matrix production, integrin expression
and inhibition of smooth muscle cell growth. Correlation was observed between integrin
expression and functional smooth muscle cell inhibition. The data support the model that
when the natural balance between the cell and mechanical forces of its environment are
altered, the cell responds by producing an altered ECM and set of integrins. Change in
integrin expression leads to differential downstream effects on stimulatory and inhibitory
secretion. The magnitude of these effects are related to the magnitude of change in
integrin expression. In the next chapter, we begin to explore whether this same type of
response to substrate mechanics is present in the inflammatory response system of
endothelial cells.
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CHAPTER 4: EFFECT OF SCAFFOLD MODULUS ON
RESPONSE TO INFLAMMATORY STIMULI
INTRODUCTION
In Chapter 3 it was found that scaffold modulus affected both the growth
stimulatory and growth inhibitory functions of endothelial cells, mediated by changes in
integrin expression. This raises the question of whether scaffold modulus can modulate
other vascular functions in the same way, or if the effect is limited to growth regulation.
A good target to be regulated in the same manner is the inflammatory system.
Like the growth regulatory system, the endothelial cell inflammatory response consists of
two complementary systems: immune stimulators (cytokines) and response units (surface
receptors such as ICAM-1 and VCAM-1). Additionally, integrin expression is known to
be reled to the activation of the NF-kB pathway, which is involved in the production of
cytokines as well as the expression of surface adhesion molecules such as ICAM and
VCAM.70
In order to answer the question of if and how scaffold modulus affects this
system, we examined several aspects of the endothelial cell inflammatory system.
Cytokine secretion (including MCP-1, IL-6 and IL-8) was examined, as was cell surface
expression of adhesion molecules ICAM and VCAM along with their soluble
counterparts. Finally, changes in endothelial cell inflammatoryfunction were assessed by
examining alterations in the ability of endothelial cells to induce CD4+ T cell
proliferation. Changes in expression of these factors were then compared with changes in
integrin expression in an attempt to discern if inflammation may be regulated in a similar
manner to growth.
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METHODS
Cell Culture and Conditioned Media Preparation
Cells were engrafted onto scaffolds and cultured to confluence as outlined in
chapter 2. Conditioned media from endothelial cells activated with TNF-a (a pro-
inflammatory cytokine) was prepared for use in assays of secreted cytokines. Confluent,
1 x2cm scaffolds were incubated in lOmL full growth media (Endothelial Cell Growth
Medium + 7% FBS + 1% PS) supplemented with IOng/mL TNF-ca for 24 hours.
Conditioned media was then collected, centrifuged to remove any particulates, and the
supernantant frozen at -80C until use. Cells were recovered from scaffolds and counted
using a Coulter Counter.
Cytokine Secretion
To measure how an endothelial cell response to an immune stimulus is modulated
by substrate stiffness, cytokine secretion in response to 1 Ong/mL TNF-a was quantified.
Conditioned media containing full growth supplements plus TNF-cc was prepared as
described above. Conecntrations of several different factors, including IL-6, IL-8, MCP-
1, sICAM and sVCAM, were all measured using ELISAs from R&D according to kit
directions.
Surface Receptor Flow Cytometry
The presentation of ICAM- I and VCAM- 1 - cell surface adhesion receptors for
leukocytes - in response to an immune stimulus was measured by flow cytometry.
Confluent scaffolds were incubated in complete growth media supplemented with
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IOng/mL TNF-o for 24 hours. Scaffolds were then digested with collagenase and cells
recovered by centrifuging and counted. These cells were washed 2x with ice cold PBS +
2% heat inactivated FBS + 0.09% sodium azide (Cell Staining Buffer, BD). 3x10 5 cells
from each sample were resuspended in I00pl of staining buffer and the appropriate
volume of FITC conjugated antibody (either mouse anti-human ICAM-l or mouse anti-
human VCAM-1) added. After briefly vortexing to mix, cells were incubated on ice for
45 minutes in the dark with shaking. Cells were then centrifuged and washed 2x with ice
cold staining buffer to remove excess antibody. Finally, cells were resuspended in 500pil
of 1% paraformaldehyde in PBS. 104 cells were analyzed by flow cytometry using a
FACScalibur intstrument and CellQuest software (Becton Dickinson, San Diego, CA).
All samples were compared to similarly prepared cells stained with the appropriate FITC
conjugated isotype controls.
T Cell Proliferation Assay
In order to determine if scaffold modulus affected functional response to
inflammatory stimulus, endothelial cell induction of T cell proliferation was measured.
Endothelial cells were cultured on scaffolds under normal culture conditions for 16 days
and then exposed to IOOOU/mL IFN-y for 48 hours. Cell growth was subsequently
arrested using 50ptg/mL mitomycin C. CD4* T cells were isolated from fresh human
blood using a negative selection kit (Miltenyi). Isolated T cells were labeled with O1IM
carboxyfluorescein succinimidyl ester (CFSE, Invitrogen) for 10 minutes at 370C in
phenol red free RPMI 1640, and washed three times. Labeled CD4+ T cells were co-
cultured with scaffolds at 5x10 5 T cells per 1.25x10 5 EC (in triplicate for each scaffold
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type), in RPMI medium without phenol red, and maintained for six days. At the end of
the co-culture period, scaffolds were washed extensively, and T cells pelleted by
centrifugation. T cells were resuspended in PBS and analyzed by flow cytometry. With
this method, proliferation (i.e. division) of T cells results in less intense staining per cell
and a shift to the left (i.e. decrease) in mean fluorescence intensity.
Statistics
Statistical analyses were performed with Prism (GraphPad) or Excel (Microsoft)
software. Data are expressed as mean +/- SEM unless noted. Comparisons between
groups were made by ANOVA followed by Tukey's multiple comparison test. A value of
p < 0.05 was considered statistically significant.
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RESULTS
ICAM-1 and VCAM-1 Expression Are Dependent on Scaffold Modulus
ICAM-1 and VCAM-1 expression was assessed in two ways. First, soluble
ICAM- I and VCAM- 1 (sICAM- 1, sVCAM- 1) were measured using a colorometric
ELISA kit. Second, cell surface expression was measured using flow cytometry. sICAM-
1 had a binary distribution. At lower moduli (<= 508Pa), sICAM-1 expression was
relatively high, and was significantly lower at high moduli (>= 1062Pa) (p = 0.002 by
ANOVA between these two groups). (Figure 48) Maximum expression was 43.9 +/- 6.1
ng/10 6 cells at a modulus of 376Pa. Minimum expression was 19.3 +/- 12.3 ng/10 6 cells
at a modulus of 1345Pa. The percentage of cells positive for ICAM as measured by flow
cytometry was not significantly dependent on modulus (p = 0.09 by ANOVA), although
the linear correlation between the two was very high (r2 =0.943). However, if scaffolds
are sorted into the same groups as the sICAM samples (<=508Pa, >=1 062Pa), the
difference between these two groups is significant (p = 0.003). (Figure 48)
sVCAM-1 was also dependent on modulus (p 0.02 by ANOVA). (Figure 49)
Expression was low at very low moduli (minimum of 33.6 +/- 1.8 ng/10 6 cells at 49.9Pa),
but reaches a maximum of 55.3 +/- 2.3 ng/1 06 cells at 173Pa and then decreases linearly
to 27.7 +/- 4.7 ng/10 6 cells at 1345Pa. VCAM as measured by flow cytometry follows a
different pattern, but is also dependent on modulus (p = 0.004 by ANOVA). (Figure 49)
Percent positive expression was highest on scaffolds of 49.9Pa, with 18.75 +/- 0.2 percent
positive cells. Positive expression then falls monotonically with modulus to a low of 1.6
+/- 0.4 percent positive cells at 1345Pa. A logarithmic curve can be fit to the data with an
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r2= 0.94. The reason for the differences between soluble and surface VCAM- 1
expression patterns is not clear.
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Figure 48: ICAM-1 Expression is Dependent on Scaffold Modulus. Top: Soluble
ICAM-1 levels fall into two groups: high at low moduli, and low at high moduli. The
difference between the two groups is significant (p = 0.002 by ANOVA). Bottom: Cell
surface ICAM- 1 correlates strongly with modulus, but dependence on modulus is only
significant (p = 0.003) when divided into two groups as with sICAM- 1.
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Figure 49: VCAM-1 Expression is Dependent on Scaffold Modulus. Top: sVCAM
secretion is dependent on scaffold modulus (p = 0.01 by ANOVA). sVCAM expression is
linearly correlated to modulus at >=1 73Pa (r2 = 0.98). Bottom: Cell surface expression
(% positive cells) is dependent on modulus (p = 0.004), and can be fit with a logarithmic
curve (r2 = 0.943).
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Cytokine Secretion By Endothelial Cells is Independent of Scaffold Modulus
Three cytokines (MCP1, IL6, and IL8) were assayed for in the conditioned media
of TNF-a stimulated endothelial cells using colorometric ELISA kita. In general, the
results indicate that the level of these cytokines is very low, and that their secretion is
independent of scaffold modulus.
MCP-1 secretion was independent of modulus (p = 0.58 by ANOVA). (Figure 50)
Secretion ranged from 3.05 +/- 0.58 ng/10 6 cells at 49.9Pa up to 3.76 +/- 0.08 ng/10 6 cells
at 508Pa, but this difference was not statistically significant. (It should be additionally
noted that MCP-1 secretion on all scaffolds was much lower than on two-dimensional
controls [13.4 +/- 0.8 ng/10 6 cells, data not shown]. Compared to the difference between
secretion on scaffolds and in 2D, the changes induced by modulus are extremely small
and almost certainly functionally significant in any case.)
Similarly, IL8 secretion was also independent of modulus (p = 0.08 by ANOVA).
(Figure 51) Secretion ranged from 104.0 +/- 6.1 ng/10 6 cells at 508Pa up to 142.4 +/-
12.9 ng/10 6 cells at 1345Pa. Like with MCP1, secretion on all scaffolds was much lower
than on two-dimensional controls [746.5 +/- 97.4 ng/l 06 cells, data not shown]. The
changes induced by modulus are extremely small when compared to the difference
between 2D culture and culture on scaffolds, and are not likely to be functional.
Finally, IL6 secretion was found to be dependent on scaffold modulus (p = 0.02
by ANOVA), and the data was fit fairly well with a parabolic curve (r2 = 0.696) with a
minimum between 508Pa and 1062Pa. (Figure 52) However, the absolute difference
between scaffolds was small, ranging from 9.5 +/- 1.9 ng/10 6 cells at 508Pa up to 16.2 +/-
3.6 ng/10 6 cells at 49.9Pa, a difference which is not statistically significant by itself.
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(Again, this difference is very small in absolute terms, and is dwarfed by the difference in
secretion between 2D culture [221.2 +/- 66.4 ng/1 06 cells, data not shown] and culture on
scaffolds - a difference of a order of magnitude.)
In general, it appears that cytokine secretion is not strongly affected by scaffold
modulus.
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Figure 50: MCP1 Secretion is Independent of Scaffold Modulus. There does not
appear to be a correlation between MCPI secretion and modulus, and the absolute
difference between highest and lowest values is small.
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Figure 51: IL8 Secretion is Independent of Modulus. There does not appear to be a
correlation between IL8 secretion and modulus, and the absolute difference between
highest and lowest values is small.
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Figure 52: IL6 Secretion May Be Dependent on Modulus. 1-way ANOVA suggests
that IL6 secretion is dependent on modulus (p = 0.02), and the data can be fit fairly well
with a parabolic curve (r2 = 0.696). However, the difference between the lowest and
highest levels is not significantly different, and the absolute differences are small.
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Endothelial Cell Induced T Cell Proliferation Is Significantly Affected By Scaffold
Modulus
CD4+ T cell proliferation in response to exposure to endothelial cells from
scaffolds of various stiffness was measured using a CFSE analysis method, where
decreased proliferation is correlated with an increase in T cell mean fluorescence
intensity (MFI).
MFI was maximal (and T cell proliferation minimal) at 49.9Pa, with a value of
65.9 +/- 4.8. MFI was minimal (and T cell proliferation maximal) at a scaffold modulus
of 1345Pa, with a value of 153.7 +/- 4.7. MFI values increase monotonically (and
proliferation decreases monotonically) with increasing modulus. The data is well fit with
a logarithmic curve, with r2 = 0.98. (Figure 53) Overall, the data indicate that
proliferation is decreased when T cells are exposed to endothelial cells grown on stiff
scaffolds when compared to exposure to endothelial cells from softer scaffolds.
CD4+ T cell proliferation can be stimulated by a number of endothelial cell
surface markers, including ICAM- 1 and VCAM- 1. Our data show that MFI is linearly
correlated with cell surface expression of both ICAM-1 (r2 = 0.81) and VCAM-1 (r2
0.95). (Figure 54)
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Figure 53: Endothelial Cell Induced T Cell Proliferation Is Increased When
Endothelial Cells Are Cultured on Softer Scaffolds. Top: Mean fluorescence intensity
of T cells, which decreases with increasing T cell number and proliferation, is minimal at
49.9Pa and increases with increasing scaffold stiffness.
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Figure 54: T Cell MFI is Linearly Related to Endothelial Cell Surface Expression of
ICAM-1 and VCAM-1. Top: T cell MFI decreased linearly (i.e. cell number increased)
with an increase in endothelial cell ICAM- I expression. Bottom: T cell MFO decreased
linearly (i.e. cell number increased) with an increase in endothelial cell VCAM-1
expression.
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MCP-1 Recruits monocytes to sites of N/A
injury and infection
IL-8 Neutrophil chemotaxis and N/A
activation
IL-6 Monocyte chemotaxis and 828Pa
activation
ICAM-1 Adhesion to, and migration 1345Pa
into, vessel wall by
leukocytes
VCAM-1 Involved in adhesion of 1345Pa
leukocytes to the vessel wall
CD4+ T Cell In vivo, activated endothelial 1345Pa
Proliferation cells induce proliferation of
these cells which are involved
in many aspects of the
immune response. This
function is greatly decreased
in 3D culture compared to 2D
culture.
Table 5: Summary of Endothelial Cell Immune Response Data
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DISCUSSION
Prior to completing the work of this chapter, there was reason to believe that
scaffold modulus would affect cytokine secretion. Cytokine secretion by endothelial cells
is regulated by the NF-kB pathway, which is upregulated by C5 P1 integrin expression. 70
Additionally, previous work (unpublished) from our lab has suggested that integrins CAsp
and aCp 3 are important in the production of cytokines by endothelial cells. When these
integrins are neutralized, or when endothelial cells are cultured on Gelfoam, where levels
of these integrins are naturally lower than in 2D culture (unpublished), production of
cytokines is decreased. As our data (figures 39-40) suggest that integrin expression levels
are dependent on substrate modulus we examined how substrate modulus affects the
secretion of cytokines by endothelial cells in response to inflammatory stimuli.
There was essentially no dependence of cytokine (MCPI, 1L8, IL6) secretion on
modulus. Although IL-6 was statistically dependent on modulus, the absolute range of
values was very small, and unlikely to be functionally significant. This does not
necessarily contradict the finding discussed above of the integrin dependence of cytokine
secretion. Integrin expression on 3D gelatin scaffolds is in general lower than in 2D
culture, as is cytokine secretion.7 It is possible that any affect of integrin expression has
already been saturated just by the transition from 2D to 3D culture, and a further
reduction in integrin levels would have no effect.
The expression of soluble and surface expressed ICAM- 1 and VCAM-1, which
are also regulated by the NF-kB pathway, by TNF-a stimulated endothelial cells was also
examined. ICAM-1 (Intercellular Cell Adhesion Molecule 1) is a cell adhesion molecule
involved in the adhesion of leukocytes to, and migration into, the blood vessel wall
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following an inflammatory stimulus. ICAM- I is constitutively expressed on endothelial
cells, but is strongly and quickly upregulated by stimulation with cytokines such as TNF-
cc. ICAM-I binds to a number of ligands present on immune cells, including Macrophage
Adhesion Ligand-l (Mac-1) and Leukocyte Function Associated Antigen-I (LFA-1).
These are both integrins containing a P2 chain found only on leukocytes. 1
Like ICAM-1, VCAM-1 (Vascaular Cell Adhesion Molecule 1) is involved in the
adhesion of leukocytes to the vessel wall. Although similar in function to ICAM-1,
VCAM-1 is not constitutively expressed on endothelial cells, and is transcriptionally
upregulated by inflammatory cytokines including TNF-ac. VCAM-1 also has different
targets on leukocytes than ICAM-1. A major target of endothelial cell VCAM-1 is
integrin a4bl, also known as Very Late Antigen 4 (VLA-4), expressed on leukocytes. 7 1
ICAM-1 and VCAM-I are also markers of atherosclerotic disease, as both are
expressed on atherosclerotic plaques. Additionally, blood levels of soluble versions of
ICAM- 1 and VCAM- I are predictive for atherosclerosis in healthy and high risk patients,
respectively. 7 1 Since the scaffolds used in this work spanned in modulus from that of a
healthy vessel up to the low end of measured values for atherosclerotic plaques (see
Chapter 3), we were interested to see how our scaffolds would affect expression of these
molecules.
Soluble and surface ICAM-I expression fell into two groups - high expression
levels at low moduli, and low expression levels at high moduli (>= 1062Pa). Surface
expression correlates with integrin cC surface expression (geometric mean of
fluorescence, r2= 0.8), as well as avP3 surface expression (percent positive cells, r2
0.77). Like ICAM-1, VCAM-l surface expression was also dependent on substrate
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modulus, and correlated linearly with aC, 3 percent positive cells (r2= 0.79). When
VCAM- 1 surface expression was compared to cs surface expression, however a pattern
similar to that of smooth muscle cell inhibition versus a 5 surface expression was seen: a
low level plateau at low OC expression, followed by a sharp increase in VCAM when cX
plateaus. This may indicate that similar pathways are involved in integrin mediated
regulation of both smooth muscle cell inhibition and inflammatory response, although it
may also point to integrin mediated upregulation of the NF-kB pathway.
Thefunctional effect of the change in endothelial cell inflammatory state in
response to changes in scaffold modulus was examining by measuring CD4+ T cell
proliferation. CD4+ T cells serve a wide variety of roles in the immune system,
functioning as helper T cells (assisting in the functions of other immune cells), memory T
cells (which "remember" past infections), and regulatory T cells (help keep T cell
mediated immunity in check)72. Immunologically activated endothelial cells express cell
surface markers (principally MHCII 73'74 - an antigen presenting molecule, although
ICAM 75'76 and VCAM7 7'78 have both also been implicated) which induce proliferation of
these cells. Past work has shown that embedding endothelial cells in gelatin scaffolds
greatly reduces this endothelial cell mediated induction of CD4+ T cell proliferation.7
In this work, we showed that endothelial cell induced proliferation of CD4+ T
cells is greatly affected by scaffold modulus. Endothelial cells cultured on stiff scaffolds
induced significantly less T cell proliferation than endothelial cells cultured on softer
scaffolds. Although VCAM and ICAM do not directly induce CD4+ T cell proliferation,
the decrease in MFI of T cells was linearly related to both VCAM-l (r2 = 0.92) and
ICAM-1 (r2 = 0.72) expression. The ICAM-I and VCAM-1 data combined with the T
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cell proliferation data suggests that the overall inflammatory state of the endothelial cell
is reduced when cultured on stiffer scaffolds compared to softer ones.
Although more data is needed, it seems that the model developed in Chapter 3 for
growth regulation may also applicable to the endothelial cell inflammatory response.
Changes in the balance of forces on the cell lead to altered ECM and integrin expression,
leading to changes in the downstream functionality of the cell, with different responses
being altered in different ways. In the case of inflammation, stimulatory cytokines change
only slightly in response these alterations in modulus, and therefore integrins, while
larger changes in cell adhesion molecules and induction of T cell proliferation are seen.
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CONCLUSIONS
The data in this chapter indicates that scaffold modulus is able to regulate some
aspects of the endothelial cell inflammatory response, namely the expression of cell
adhesion molecules ICAM-1 and VCAM-1, and the induction of CD4+ T cell
proliferation. On the other hand, cytokine expression was found to be unaffected by
scaffold modulus. Changes in adhesion molecule expression correlated with endothelial
cell integrin expression, suggesting that integrin mediated signaling is involved in
inflammatory regulation.
The data presented in this chapter offers an intriguing hint that modulus mediates
control of inflammatory response in a manner similar to the regulation of growth, but
there are still many questions left to answer. Future studies will focus on the pathways
involved in the regulation of ICAM-1, VCAM-1 and T cell proliferation by substrate
modulus. There are several possibilities. The NF-kB pathway is a natural target, as it is
intimately involved in the inflammatory response, and has been shown to be altered in
response to integrin expression. Alternatively, we will examine whether modulus
mediated regulation of smooth muscle cell inhibition and inflammatory response are
regulated through some common cellular pathway. If the NF-kB pathway is responsible
for the changes in ICAM-1 and VCAM-1 expression, it would also be interesting to
determine why cytokine expression was not affected, though adhesion molecule
expression was.
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK
SUMMARY
In this thesis, we examined the hypothesis that substrate physical properties can
affect the functionality of endothelial cell in three dimensional culture, and that these
changes are mediated by changes in the interface between the cells and their substrate.
Chapter 2 attempted to use gelatin scaffolds to examine the effect of a range of physical
properties, including pore size, density and modulus. Cell functions such as growth,
secretion of TGF-p1, prostacyclin, glycosaminoglycans and heparan sulfate
proteoglycans were all affected to some degree by changes of substrate properties.
However, the alteration of multiple scaffold properties confounded the analysis. Based on
Ll th % beVatIVon thaL modUUL1us seeme tohVe h1ad tit% osyt eff"t %-n CF"pter 3V- weuILIzed'
scaffolds varying in only modulus to examine the effect of changes in substrate
mechanical properties on cell biology. Various aspects of endothelial cell biology relating
to the regulation of smooth muscle cell growth (including secretion of growth factors and
heparan sulfate proteoglycans) were altered by scaffold modulus, and that these changes
in regulatory factors translated into a functional difference. Additionally, it was
discovered that endothelial cell extracellular matrix gene expression and integrin
expression were altered by substrate modulus, and that these changes correlated with the
changes in smooth muscle cell growth regulation. Based on these data, we offered a
model whereby changes in scaffold modulus upset the normal balance of forces on the
cell. The cell attempts to return to its preferred state by altering extracellular matrix and
integrin expression. The changes in integrin expression then have differential effects on
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the stimulation and inhibition of cellular growth. Stimulatory function was conserved,
changing only slightly, as was avb3 integrin associated with a proliferatory phenotype.
The change in inhibitory function was much larger, and is of similar magnitude to that of
the change in c4p1 integrin, which is related to a more quiescent, less proliferative
cellular phenotype. In Chapter 4, we attempted to determine if this same paradigm could
be applied to cellular response to inflammatory stimuli. Initial data indicates that some
aspects of endothelial cell inflammatory response, namely cell surface expression of
ICAM- 1 and VCAM-1, are altered in a manner which mirrors changes in integrin
expression and possibly can be explained by a similar model as growth regulation.
Additionally, induction of CD4+ T cell proliferation was found to be greater by
endothelial cells cultured on soft scaffolds compared to those grown on stiffer ones.
These data correlated well with ICAM and VCAM cell surface expression.
FUTURE WORK
Based on these data, future work will follow two lines of inquiry. The first line of
inquiry will be to further examine how endothelial cell inflammatory response is
modulated by substrate modulus. Initial work has shown that cell surface adhesion
molecules and T cell proliferation are affected, while cytokines are not, and that some of
these changes seem to mirror those seen in the smooth muscle cell inhibition system.
Work in this area will involve seeking other functional changes, and determining if these
follow the same pattern as well.
Second, although it appears that alterations in integrin expression may be related
to changes in cellular function, the mechanism by which this occurs is not known. There
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are many different pathways which have been shown to be activated by changes in
mechanical forces, through integrins and intermediaries such as PKC, RhoA, Ras/Rac,
etc., including the MAP kinase cascades and NF-kB pathway. 79 Activation of several of
these pathways could explain the data of this thesis. For example, activation of the ERK
1/2 and p38 MAP kinase pathways by mechanical stimuli has been implicated in the
increased inhibition of smooth muscle cell growth through the TGF-b pathway5 5 , which
also increases extracellular matrix deposition.80 Increased activation of the NF-kB
pathway could explain the increases in ICAM-1 and VCAM-1 expression. Although
changes in substrate modulus have not been specifically implicated in these systems, it
seems likely that changes in substrate stiffness could be thought of as analogous to shear
stress or cyclic strain. Elucidation of which pathways are involved will be an important
next step to understanding how changes in substrate mechanics are translated into
functional differences.
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